Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________ 
FORM 10-Q
___________________________________________ 
(Mark One)
☒Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended March 31,September 30, 2021
or
☐Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
for the transition period from                      to                     
Commission File No. 0-22818
___________________________________________ 
hain-20210930_g1.jpg
THE HAIN CELESTIAL GROUP, INC.
(Exact name of registrant as specified in its charter)
___________________________________________ 
Delaware22-3240619
(State or other jurisdiction
of incorporation)
(I.R.S. Employer Identification No.)

1111 Marcus Avenue, Lake Success, NY 11042
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (516) 587-5000
Former name, former address and former fiscal year, if changed since last report: N/A
___________________________________________ 

Table of Contents

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $.01$0.01 per shareHAINThe NASDAQ Global SelectNasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     
Yes  ý    No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes  ý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☒Accelerated filer¨
Non-accelerated filer¨Smaller reporting company☐Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes  ☐    No  ý

As of April 29,November 2, 2021, therethere were 99,720,27594,581,455 s shareshares outstanding of the registrant’s Common Stock, par value $.01$0.01 per share.

Table of Contents
THE HAIN CELESTIAL GROUP, INC.
Index
Part I - Financial InformationPage
Item 1.
3
4
5
6
8
9
Item 2.
3932
Item 3.
5742
Item 4.
5843
Part II - Other Information
Items 3, 4 and 5 are not applicable
Item 1.
5944
Item 1A.
5944
Item 2.
5944
Item 6.
6045
6146

 
1
Table of Contents
Cautionary Note Regarding Forward Looking InformationForward-Looking Statements

This Quarterly Report on Form 10-Q for the quarter ended March 31,September 30, 2021 (the “Form 10-Q”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, relating to our business and financial outlook, which are based on our current beliefs, assumptions, expectations, estimates, forecasts and projections about future events only as of the date of this Quarterly Report on Form 10-Q, and are not statements of historical fact. We make such forward-looking statements pursuant to the “safe harbor”safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Many Such statements involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of ourThe Hain Celestial Group, Inc. (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”) may differ materially from those expressed or implied by such forward-looking statements include discussions of trends and anticipated developments under the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of this Quarterly Report on Form 10-Q. In some cases, you can identify forward-looking statements by terminology such as the use ofstatements. The words “believe,” “expect,” “anticipate,” “may,” “will,” “should,” “expects,“plan,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “intends,” “predicts,“intend,” “potential,” or “continue”“will” and similar expressions or the negative of those expressions. Theseare intended to identify such forward-looking statements. Forward-looking statements include, among other things, our beliefs or expectations relating to our business strategy, growth strategy, market price, brand portfolio and productfuture performance, the seasonality of our business and our results of operations and financial condition. These forward-looking statements are not guarantees ofcondition; our strategic initiatives, business strategy, supply chain, brand portfolio and product performance; the COVID-19 pandemic; current or future performancemacroeconomic trends; and involve risks,future corporate acquisitions or dispositions.

Risks and uncertainties estimates and assumptions that are difficultmay cause actual results to predict. Therefore, our actual outcomes and results may differ materially from those expressed in these forward-looking statements. You should not place undue reliance on any of these forward-looking statements. Further, any forward-looking statement speaks only as of the date hereof, unless it is specifically otherwise stated to be made as of a different date. We undertake no obligation to further update any such statement to reflect new information, the occurrence of future events or circumstances or otherwise.

The forward-looking statements in this filing do not constitute guarantees or promisesinclude: challenges and uncertainty resulting from the impact of future performance. Factors that could cause or contribute to such differences may include, but are not limited to, competition; challenges and uncertainty resulting from the COVID-19 pandemic, the impactpandemic; our ability to manage our supply chain effectively; disruption of competitive products and changes to the competitive environment,operations at our manufacturing facilities; reliance on independent contract manufacturers; changes to consumer preferences, general economic and financial market conditions, potential legal claims and other risks relating to regulatory requirements, government investigations and other regulatory enforcement actions, the United Kingdom's exit from the European Union, consolidation of customers or the loss of a significantpreferences; customer concentration; reliance on independent distributors,distributors; the availability of organic ingredients; risks associated with our international sales and operations,operations; risks associated with outsourcing arrangements; our ability to manageexecute our supply chain effectively, volatility incost reduction initiatives and related strategic initiatives; our reliance on independent certification for a number of our products; the costreputation of commodities, ingredients, freightour Company and fuel,our brands; our ability to implementuse and protect trademarks; general economic conditions; input cost savings initiatives,inflation; the United Kingdom’s exit from the European Union; cybersecurity incidents; disruptions to information technology systems; the impact of our debt covenants, the potential discontinuation of LIBOR, our abilityclimate change; liabilities, claims or regulatory change with respect to manage our financial reporting and internal control system processes, costs incurred due to pending and future litigation, potential liability, including in connection with indemnification obligations to our former officers and members of our Board of Directors that may not be covered by insurance,environmental matters; potential liability if our products cause illness or physical harm,harm; the highly regulated environment in which we operate; pending and future litigation; compliance with data privacy laws; compliance with our credit agreement; the discontinuation of LIBOR; concentration in the ownership of our common stock; our ability to issue preferred stock; the adequacy of our insurance coverage; impairments in the carrying value of goodwill or other intangible assets, our ability to consummate divestitures, the availability of organic ingredients, disruption of operations at our manufacturing facilities, loss of one or more independent co-packers, disruption of our transportation systems, risks relating to the protection of intellectual property, the risk of liabilities and claims with respect to environmental matters, the reputation of our brands, our reliance on independent certification for a number of our productsassets; and other risks and matters described in Part I, Item 1A of the Company’sour most recent Annual Report on Form 10-K, for the fiscal year ended June 30, 2020 under the heading “Risk Factors”, and Part I, Item 2 of this Quarterly Report on Form 10-Q underand our other filings from time to time with the heading “Management’s DiscussionU.S. Securities and Analysis of Financial Condition and Results of Operations”Exchange Commission.

We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as well as in other reports that we file in the future.required by applicable law.





2
Table of Contents
PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
MARCH 31,SEPTEMBER 30, 2021 AND JUNE 30, 20202021
(In thousands, except par values)
March 31,June 30,
20212020
ASSETS
Current assets:
Cash and cash equivalents$53,014 $37,771 
Accounts receivable, less allowance for doubtful accounts of $1,178 and $638, respectively190,737 170,969 
Inventories313,898 248,170 
Prepaid expenses and other current assets38,648 95,690 
Assets held for sale0 8,334 
Total current assets596,297 560,934 
Property, plant and equipment, net311,342 289,256 
Goodwill877,723 861,958 
Trademarks and other intangible assets, net324,791 346,462 
Investments and joint ventures17,342 17,439 
Operating lease right-of-use assets90,130 88,165 
Other assets22,263 24,238 
Total assets$2,239,888 $2,188,452 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$210,223 $171,009 
Accrued expenses and other current liabilities120,498 124,045 
Current portion of long-term debt699 1,656 
Liabilities related to assets held for sale0 3,567 
Total current liabilities331,420 300,277 
Long-term debt, less current portion255,540 281,118 
Deferred income taxes36,103 51,849 
Operating lease liabilities, noncurrent portion83,564 82,962 
Other noncurrent liabilities31,579 28,692 
Total liabilities738,206 744,898 
Commitments and contingencies (Note 17)00
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: NaN0 0 
Common stock - $.01 par value, authorized 150,000 shares; issued: 109,466 and 109,123 shares, respectively; outstanding: 99,706 and 101,885 shares, respectively1,096 1,092 
Additional paid-in capital1,183,759 1,171,875 
Retained earnings650,740 614,171 
Accumulated other comprehensive loss(77,682)(171,392)
1,757,913 1,615,746 
Less: Treasury stock, at cost, 9,753 and 7,238 shares, respectively(256,231)(172,192)
Total stockholders’ equity1,501,682 1,443,554 
Total liabilities and stockholders’ equity$2,239,888 $2,188,452 
September 30,June 30,
20212021
ASSETS
Current assets:
Cash and cash equivalents$28,962 $75,871 
Accounts receivable, less allowance for doubtful accounts of $1,210 and $1,314, respectively181,048 174,066 
Inventories280,176 285,410 
Prepaid expenses and other current assets38,496 39,834 
Assets held for sale3,642 1,874 
Total current assets532,324 577,055 
Property, plant and equipment, net312,426 312,777 
Goodwill863,348 871,067 
Trademarks and other intangible assets, net308,588 314,895 
Investments and joint ventures16,718 16,917 
Operating lease right-of-use assets, net88,387 92,010 
Other assets20,474 21,187 
Total assets$2,142,265 $2,205,908 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$172,733 $171,947 
Accrued expenses and other current liabilities123,296 117,957 
Current portion of long-term debt335 530 
Total current liabilities296,364 290,434 
Long-term debt, less current portion345,414 230,492 
Deferred income taxes40,345 42,639 
Operating lease liabilities, noncurrent portion82,176 85,929 
Other noncurrent liabilities29,210 33,531 
Total liabilities793,509 683,025 
Commitments and contingencies (Note 17)00
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none— — 
Common stock - $.01 par value, authorized 150,000 shares; issued: 109,568 and 109,507 shares, respectively; outstanding: 94,576 and 99,069 shares, respectively1,096 1,096 
Additional paid-in capital1,191,817 1,187,530 
Retained earnings710,636 691,225 
Accumulated other comprehensive loss(93,974)(73,011)
1,809,575 1,806,840 
Less: Treasury stock, at cost, 14,992 and 10,438 shares, respectively(460,819)(283,957)
Total stockholders’ equity1,348,756 1,522,883 
Total liabilities and stockholders’ equity$2,142,265 $2,205,908 
See notes to consolidated financial statements.
3
Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED MARCH 31,SEPTEMBER 30, 2021 AND 2020
(In thousands, except per share amounts) 
 Three Months Ended March 31,Nine Months Ended March 31,
 2021202020212020
Net sales$492,604 $553,297 $1,519,649 $1,542,157 
Cost of sales362,698 420,902 1,140,614 1,206,324 
Gross profit129,906 132,395 379,035 335,833 
Selling, general and administrative expenses74,223 85,447 236,995 245,205 
Amortization of acquired intangible assets2,145 3,174 6,771 9,446 
Productivity and transformation costs4,553 11,514 12,371 37,949 
Proceeds from insurance claim(592)(400)(592)(2,962)
Long-lived asset and intangibles impairment0 13,525 57,676 15,414 
Operating income49,577 19,135 65,814 30,781 
Interest and other financing expense, net2,030 4,037 6,820 15,068 
Other expense (income), net1,566 (260)(852)2,312 
Income from continuing operations before income taxes and equity in net (income) loss of equity-method investees45,981 15,358 59,846 13,401 
Provision (benefit) for income taxes11,797 (10,242)33,197 (9,753)
Equity in net (income) loss of equity-method investees(70)564 1,025 1,219 
Net income from continuing operations$34,254 $25,036 $25,624 $21,935 
Net (loss) income from discontinued operations, net of tax0 (697)11,255 (105,581)
Net income (loss)$34,254 $24,339 $36,879 $(83,646)
Net income (loss) per common share:
Basic net income per common share from continuing operations$0.34 $0.24 $0.25 $0.21 
Basic net (loss) income per common share from discontinued operations0 (0.01)0.11 (1.01)
Basic net income (loss) per common share$0.34 $0.23 $0.36 $(0.80)
Diluted net income per common share from continuing operations$0.34 $0.24 $0.25 $0.21 
Diluted net (loss) income per common share from discontinued operations0 (0.01)0.11 (1.01)
Diluted net income (loss) per common share$0.34 $0.23 $0.36 $(0.80)
Shares used in the calculation of net income (loss) per common share:
Basic99,831 104,032 100,502 104,192 
Diluted101,596 104,337 101,385 104,489 
 Three Months Ended September 30,
 20212020
Net sales$454,903 $498,627 
Cost of sales349,485 379,463 
Gross profit105,418 119,164 
Selling, general and administrative expenses73,989 79,521 
Amortization of acquired intangible assets2,095 2,433 
Productivity and transformation costs3,983 1,433 
Proceeds from insurance claim(196)— 
Long-lived asset impairment— 32,497 
Operating income25,547 3,280 
Interest and other financing expense, net1,856 2,453 
Other income, net(788)(1,373)
Income from continuing operations before income taxes and equity in net loss of equity-method investees24,479 2,200 
Provision for income taxes4,542 12,962 
Equity in net loss of equity-method investees526 19 
Net income (loss) from continuing operations$19,411 $(10,781)
Net income from discontinued operations, net of tax— 11,266 
Net income$19,411 $485 
Net income (loss) per common share:
Basic net income (loss) per common share from continuing operations$0.20 $(0.11)
Basic net income per common share from discontinued operations— 0.11 
Basic net income per common share$0.20 $— 
Diluted net income (loss) per common share from continuing operations$0.20 $(0.11)
Diluted net income per common share from discontinued operations— 0.11 
Diluted net income per common share$0.20 $— 
Shares used in the calculation of net income (loss) per common share:
Basic97,121 101,558 
Diluted97,438 101,558 

See notes to consolidated financial statements.
4
Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)INCOME (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED MARCH 31,SEPTEMBER 30, 2021 AND 2020
(In thousands)
 Three Months Ended
March 31, 2021March 31, 2020
 
Pre-tax
amount
Tax (expense) benefitAfter-tax amount
Pre-tax
amount
Tax (expense) benefitAfter-tax amount
Net income$34,254 $24,339 
Other comprehensive income (loss):
Foreign currency translation adjustments before reclassifications$1,672 $0 1,672 $(52,315)$0 (52,315)
Reclassification of currency translation adjustment included in Net income from continuing operations, net of tax14,725 0 14,725 0 0 0 
Change in deferred gains (losses) on cash flow hedging instruments322 (68)254 134 (25)109 
Change in deferred gains (losses) on net investment hedging instruments3,810 (800)3,010 0 0 0 
Total other comprehensive income (loss)$20,529 $(868)$19,661 $(52,181)$(25)$(52,206)
Total comprehensive income (loss)$53,915 $(27,867)
 Nine Months Ended
March 31, 2021March 31, 2020
 Pre-tax
amount		Tax (expense) benefitAfter-tax amountPre-tax
amount		Tax (expense) benefitAfter-tax amount
Net income (loss)$36,879 $(83,646)
Other comprehensive income (loss):
Foreign currency translation adjustments before reclassifications$80,491 $0 80,491 $(42,602)$0 (42,602)
Reclassification of currency translation adjustment included in Net income from continuing operations, net of tax15,906 0 15,906 95,120 0 95,120 
Change in deferred gains (losses) on cash flow hedging instruments474 (100)374 108 (25)83 
Change in deferred (losses) gains on net investment hedging instruments(3,875)814 (3,061)0 0 0 
Total other comprehensive income (loss)$92,996 $714 $93,710 $52,626 $(25)$52,601 
Total comprehensive income (loss)$130,589 $(31,045)
 Three Months Ended
September 30, 2021September 30, 2020
 
Pre-tax
amount
Tax (expense) benefitAfter-tax amount
Pre-tax
amount
Tax (expense) benefitAfter-tax amount
Net income$19,411 $485 
Other comprehensive (loss) income:
Foreign currency translation adjustments before reclassifications$(22,805)$— (22,805)$33,957 $— 33,957 
Change in deferred gains on cash flow hedging instruments44 (9)35 50 (10)40 
Change in deferred gains (losses) on net investment hedging instruments2,287 (480)1,807 (3,787)795 (2,992)
Total other comprehensive (loss) income$(20,474)$(489)$(20,963)$30,220 $785 $31,005 
Total comprehensive (loss) income$(1,552)$31,490 
See notes to consolidated financial statements.
5
Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED MARCH 31,SEPTEMBER 30, 2021
(In thousands, except par values)

Accumulated Common StockAdditional   
Accumulated
Other
 
Common StockAdditional   Other   AmountPaid-inRetainedTreasury StockComprehensive 
 AmountPaid-inRetainedTreasury StockComprehensive  Sharesat $.01CapitalEarningsSharesAmountLossTotal
Sharesat $.01CapitalEarningsSharesAmountIncome (Loss)Total
Balance at June 30, 2020109,123 $1,092 $1,171,875 $614,171 7,238 $(172,192)$(171,392)$1,443,554 
Balance at June 30, 2021Balance at June 30, 2021109,507 $1,096 $1,187,530 $691,225 10,438 $(283,957)$(73,011)$1,522,883 
Net incomeNet income485 485 Net income19,411 19,411 
Cumulative effect of adoption of ASU 2016-13
(310)(310)
Other comprehensive income31,005 31,005 
Other comprehensive lossOther comprehensive loss(20,963)(20,963)
Issuance of common stock pursuant to stock-based compensation plansIssuance of common stock pursuant to stock-based compensation plans54 1 (1)0 Issuance of common stock pursuant to stock-based compensation plans61 — — — 
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plansShares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans20 (468)(468)Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans29 (1,175)(1,175)
Repurchases of common stockRepurchases of common stock1,281 (42,052)(42,052)Repurchases of common stock4,525 (175,687)(175,687)
Stock-based compensation expenseStock-based compensation expense4,367 4,367 Stock-based compensation expense4,287 4,287 
Balance at September 30, 2020109,177 $1,093 $1,176,241 $614,346 8,539 $(214,712)$(140,387)$1,436,581 
Net income2,140 2,140 
Other comprehensive income43,044 43,044 
Issuance of common stock pursuant to stock-based compensation plans162 2 (2)0 
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans38 (1,255)(1,255)
Repurchases of common stock923 (29,684)(29,684)
Stock-based compensation expense3,823 3,823 
Balance at December 31, 2020109,339 $1,095 $1,180,062 $616,486 9,500 $(245,651)$(97,343)$1,454,649 
Net income34,254 34,254 
Other comprehensive income19,661 19,661 
Issuance of common stock pursuant to stock-based compensation plans127 1 (1)0 
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans49 (2,018)(2,018)
Repurchases of common stock204 (8,562)(8,562)
Stock-based compensation expense3,698 3,698 
Balance at March 31, 2021109,466 $1,096 $1,183,759 $650,740 9,753 $(256,231)$(77,682)$1,501,682 
Balance at September 30, 2021Balance at September 30, 2021109,568 $1,096 $1,191,817 $710,636 14,992 $(460,819)$(93,974)$1,348,756 

See notes to consolidated financial statements.





6
Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED MARCH 31,SEPTEMBER 30, 2020
(In thousands, except par values)

Accumulated Common StockAdditional   
Accumulated
Other
 
Common StockAdditional   Other   AmountPaid-inRetainedTreasury StockComprehensive 
 AmountPaid-inRetainedTreasury StockComprehensive  Sharesat $.01CapitalEarningsSharesAmountLossTotal
Sharesat $.01CapitalEarningsSharesAmountIncome (Loss)Total
Balance at June 30, 2019108,833 $1,088 $1,158,257 $695,017 4,614 $(110,039)$(225,004)$1,519,319 
Net loss(107,021)(107,021)
Balance at June 30, 2020Balance at June 30, 2020109,123 $1,092 $1,171,875 $614,171 7,238 $(172,192)$(171,392)$1,443,554 
Net incomeNet income485 485 
Cumulative effect of adoption of ASU 2016-02
Cumulative effect of adoption of ASU 2016-02
(439)(439)
Cumulative effect of adoption of ASU 2016-02
(310)(310)
Other comprehensive income
Other comprehensive income
56,110 56,110 
Other comprehensive income
31,005 31,005 
Issuance of common stock pursuant to stock-based compensation plansIssuance of common stock pursuant to stock-based compensation plans40 1 (1)0 Issuance of common stock pursuant to stock-based compensation plans54 1 (1)— 
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans17 (312)(312)
Stock-based compensation expense3,281 3,281 
Balance at September 30, 2019108,873 $1,089 $1,161,537 $587,557 4,631 $(110,351)$(168,894)$1,470,938 
Net loss(964)(964)
Other comprehensive income48,697 48,697 
Issuance of common stock pursuant to stock-based compensation plans146 2 (2)0 
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans27 (671)(671)
Stock-based compensation expense3,083 3,083 
Balance at December 31, 2019109,019 $1,091 $1,164,618 $586,593 4,658 $(111,022)$(120,197)$1,521,083 
Net income24,339 24,339 
Other comprehensive loss(52,206)(52,206)
Issuance of common stock pursuant to stock-based compensation plans70 1 (1)0 
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plansShares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans20 (523)(523)Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans20 (468)(468)
Repurchases of common stockRepurchases of common stock2,439 (57,406)(57,406)Repurchases of common stock1,281 (42,052)(42,052)
Stock-based compensation expenseStock-based compensation expense3,761 3,761 Stock-based compensation expense4,367 4,367 
Balance at March 31, 2020109,089 $1,092 $1,168,378 $610,932 7,117 $(168,951)$(172,403)$1,439,048 
Balance at September 30, 2020Balance at September 30, 2020109,177 $1,093 $1,176,241 $614,346 8,539 $(214,712)$(140,387)$1,436,581 

See notes to consolidated financial statements.
7
Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE NINETHREE MONTHS ENDED MARCH 31, SEPTEMBER 30, 2021 AND 2020
(In thousands)
 Nine Months Ended March 31,
 20212020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)$36,879 $(83,646)
Net income (loss) from discontinued operations11,255 (105,581)
Net income from continuing operations25,624 21,935 
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities from continuing operations:
Depreciation and amortization37,768 40,069 
Deferred income taxes3,216 (9,035)
Equity in net loss of equity-method investees1,025 1,219 
Stock-based compensation, net11,888 9,581 
Long-lived asset and intangibles impairment57,676 15,414 
Other non-cash items, net494 2,335 
(Decrease) increase in cash attributable to changes in operating assets and liabilities:
Accounts receivable(20,721)(30,870)
Inventories(60,304)47,280 
Other current assets56,487 10,302 
Other assets and liabilities(952)(1,166)
Accounts payable and accrued expenses34,316 (42,972)
Net cash provided by operating activities from continuing operations146,517 64,092 
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment(53,062)(46,961)
Proceeds from sale of businesses, net and other27,094 14,428 
Net cash used in investing activities from continuing operations(25,968)(32,533)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility206,000 197,000 
Repayments under bank revolving credit facility(231,000)(254,500)
Repayments under term loan0 (206,250)
Proceeds from discontinued operations entities0 305,247 
Repayments of other debt, net(1,917)(1,502)
Share repurchases(80,298)(57,406)
Shares withheld for payment of employee payroll taxes(3,741)(1,506)
Net cash used in financing activities from continuing operations(110,956)(18,917)
Effect of exchange rate changes on cash from continuing operations5,650 (2,110)
CASH FLOWS FROM DISCONTINUED OPERATIONS
Cash used in operating activities0 (6,146)
Cash provided by investing activities0 297,592 
Cash used in financing activities0 (299,418)
Effect of exchange rate changes on cash from discontinued operations0 (537)
Net cash flows used in discontinued operations0 (8,509)
Net increase in cash and cash equivalents15,243 2,023 
Cash and cash equivalents at beginning of period37,771 39,526 
Cash and cash equivalents at end of period$53,014 $41,549 
 Three Months Ended September 30,
 20212020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income$19,411 $485 
Net income from discontinued operations— 11,266 
Net income (loss) from continuing operations19,411 (10,781)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities from continuing operations:
Depreciation and amortization10,855 13,761 
Deferred income taxes(2,105)(930)
Equity in net income of equity-method investees526 19 
Stock-based compensation4,287 4,367 
 Long-lived asset impairment— 32,497 
Gain on sale of assets(276)— 
Gain on sale of businesses— (620)
Other non-cash items including unrealized currency gains, net(1,093)(1,047)
(Decrease) increase in cash attributable to changes in operating assets and liabilities:
Accounts receivable(9,443)(3,575)
Inventories2,277 (44,962)
Other current assets900 37,869 
Other assets and liabilities(1,566)(1,541)
Accounts payable and accrued expenses13,813 15,612 
Net cash provided by operating activities from continuing operations37,586 40,669 
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment(17,810)(12,155)
Investment in joint venture(408)— 
Proceeds from sale of assets164 — 
Proceeds from sale of businesses and other— 4,427 
Net cash used in investing activities from continuing operations(18,054)(7,728)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility120,000 55,000 
Repayments under bank revolving credit facility(5,000)(47,000)
Repayments of other debt, net(237)(1,439)
Shares withheld for payment of employee payroll taxes(1,175)(468)
Share repurchases(177,103)(42,052)
Net cash used in financing activities from continuing operations(63,515)(35,959)
Effect of exchange rate changes on cash from continuing operations(2,926)2,500 
Net decrease in cash and cash equivalents(46,909)(518)
Cash and cash equivalents at beginning of period75,871 37,771 
Cash and cash equivalents at end of period$28,962 $37,253 

See notes to consolidated financial statements.







8
Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Amounts in thousands, except par values and per share amounts)data)

1.    BUSINESS

The Hain Celestial Group, Inc., a Delaware corporation (collectively along with its subsidiaries, the “Company,” and herein referred to as “Hain Celestial,” “we,” “us” andor “our”), was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — To Create and Inspire A Healthier Way of LifeTM andtenet. The Company continues to be thea leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores in over 7580 countries worldwide. The Company operates under 2 reportable segments: North America and International.

The Company manufactures, markets, distributes and sells organic and natural products under brand names, with many recognized brands in the various market categories it serves, including Celestial Seasonings®, Clarks™, Cully & Sully®, Earth’s Best®, Ella’s Kitchen®, Farmhouse Fare™, Frank Cooper’s®, GG UniqueFiber®, Gale’s®, Garden of Eatin’®, Hain Pure Foods®, Hartley’s®, Health Valley®, Imagine®, Joya®, Lima®, Linda McCartney's®™ (under license), MaraNatha®, Natumi®, New Covent Garden Soup Co.®, Robertson’s®, Sensible Portions®, Spectrum®, Sun-Pat®, Terra®, The Greek Gods®, William’s™, Yorkshire Provender® and Yves Veggie Cuisine®. The Company’s personal care products are marketed under the Alba Botanica®, Avalon Organics®, Earth’s Best®, JASON®, Live Clean®, One Step® and Queen Helene® brands.

The Company continues to execute the four key pillars of its strategy: (1) simplify its portfolio; (2) strengthen its capabilities; (3) expand profit margins and cash flow; and (4) reinvigorate profitable topline growth.The Company has executed this strategy, with a focus ondiscontinuing uneconomic investment, realigning resources to coincide with brand importance, reducing unproductive stock-keeping units (“SKUs”) and brands and reassessing current pricing architecture. As part of this initiative, the Company reviewed its product portfolio within North America and divided it into “Get Bigger” and “Get Better” brand categories.

•The Company’s “Get Bigger” brands represent its strongest brands with higher margins, which compete in categories with strong growth potential. The Company has concentrated its investment in marketing, innovation and other resources to prioritize spending for these brands, in an effort to reinvigorate profitable topline growth, optimize assortment and increase share of distribution.

•The Company’s “Get Better” brands are the brands in which the Company is primarily focused on simplification and expansion of profit margin. Some of these brands have historically been low margin, non-strategic brands that added complexity with minimal benefit to the Company’s operations.

In addition, as part of the Company’s overall strategy, the Company may seek to dispose of businesses and brands that are less profitable or are otherwise less of a strategic fit within its core portfolio. During fiscal 2019, for example, the Company divested its Hain Pure Protein reportable segment and its WestSoy® tofu, seitan and tempeh businesses. In fiscal 2020, the Company divested its Tilda business and its Arrowhead Mills®, SunSpire®, Europe's Best®, Casbah®, Rudi’s Gluten-Free Bakery™, Rudi’s Organic Bakery® and Fountain of Truth™ brands. In fiscal 2021, the Company divested Danival®, its U.K. fruit business, primarily consisting of the Orchard House® Foods Limited business and associated brands, and subsequent to the quarter ended March 31, 2021, the Company completed the sale of both WestSoy® and Dream®.

Productivity and Transformation Costs
In fiscal 2019, the Company announced an initiative that sought to identify areas of cost savings and operating efficiencies to expand profit margins and cash flow. As part of this initiative, during fiscal 2020, the Company began the integration of its United States and Canada operations in alignment with the North America reportable segment structure. In addition, during fiscal 2021, the Company initiated cost reduction programs for its international businesses in the United Kingdom and Europe. The Company will carry out additional productivity initiatives under this strategy in fiscal 2021.

Productivity and transformation costs include costs such as consulting and severance costs relating to streamlining the Company’s manufacturing plants, co-packers and supply chain, eliminating served categories or brands within those categories, and product rationalization initiatives which are aimed at eliminating slow moving SKUs.

9
Table of Contents
Discontinued Operations
On August 27, 2019, the Company and Ebro Foods S.A. entered into, and consummated the transactions contemplated by, an agreement relating to the sale and purchase of the Tilda Group Entities and certain other assets.

On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for the Plainville Farms business, a component of the Company’s Hain Pure Protein Corporation (“HPPC”) operating segment. On June 28, 2019, the Company completed the sale of the remainder of HPPC and Empire Kosher which included the FreeBird and Empire Kosher businesses. These dispositions were undertaken to reduce complexity in the Company’sThe financial statements separately report discontinued operations and simplify the Company’s brand portfolio, in addition to allowing additional flexibility to focus on opportunities for growth and innovation in the Company’s more profitable and faster growing core businesses. Collectively, these dispositions were reported in the aggregate as the Hain Pure Protein reportable segment.

These dispositions represented strategic shifts that had a major impact on the Company’sresults of continuing operations and financial results, and therefore, the Company is presenting the operating results and cash flows of the Tilda operating segment and the Hain Pure Protein reportable segment within(see Note 4). All footnotes exclude discontinued operations in the current and prior periods. See Note 4, Dispositions, for additional information.unless otherwise noted.

2.    BASIS OF PRESENTATION

The Company’s unaudited consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net lossincome includes the Company's equity in the current earnings or losses of such companies.

The Company's unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 20202021 (the “Form 10-K”). The amounts as of and for the periods ended June 30, 20202021 are derived from the Company’s audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the ninethree months ended March 31,September 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2021.2022. Please refer to the Notes to the Consolidated Financial Statements as of June 30, 20202021 and for the fiscal year then ended included in the Form 10-K for information not included in these condensed notes.

All amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, unless otherwise indicated.

Reclassifications

Certain prior year amounts have been reclassified to conform with current year presentation.

Transfer of Financial Assets

The Company has non-recourse accounts receivable financing arrangements in which eligible receivables are sold to third-party buyers in exchange for cash. The Company transferred accounts receivables in their entirety to the buyers and satisfied all of the conditions to report the transfer of financial assets in their entirety as a sale. The principal amount of receivables sold under these arrangements was $22,889 and $14,360 during the three months ended September 30, 2021 and 2020, respectively. The incremental cost of accounts receivable financing arrangements is included in Interest and other financing expense, net in the Company’s Consolidated Statements of Operations. The proceeds from the sale of receivables are included in cash from operating activities in the accompanying Consolidated Statements of Cash Flows.

9
Table of Contents
Significant Accounting Policies

The Company's significant accounting policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements in the Form 10-K. Included herein are certain updates to those policies.

Valuation of Accounts Receivable

The Company maintains an allowance for expected uncollectible accounts receivable which is recorded as an offset to trade accounts receivable on the Consolidated Balance Sheets. Effective July 1, 2020, collectability of accounts receivable is assessed by applying a historical loss-rate methodology in accordance with Accounting Standards Codification ("ASC") Topic 326, Financial Instruments - Credit Losses, adjusted as necessary based on the Company's review of accounts receivable on an individual basis, specifically identifying customers with known disputes or collectability issues, and experience with trade receivable aging categories. The Company also considers market conditions and current and expected future economic conditions to inform adjustments to historical loss data. Changes to the allowance, if any, are classified as bad debt provisions in the Consolidated Statements of Operations.
10
Table of Contents
Recently Adopted Accounting Pronouncements

In June 2016,Issued by the Financial Accounting Standards Board ("FASB"(“FASB”) issued Accounting Standards Update ("ASU") 2016-13,, ASC 815, MeasurementDerivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of Credit Losses on Financial Instruments, which requires measurementfinancial statements with an enhanced understanding of: (a) how and recognition of expected versus incurred credit losseswhy an entity uses derivative instruments, (b) how the entity accounts for most financial assets. The ASU applies to tradederivative instruments and other receivables recorded on the Consolidated Balance Sheets. The Company adopted the standard on July 1, 2020 using the modified retrospective transition method, recognizingrelated hedged items and (c) how derivative instruments and related hedged items affect an adjustment to beginning retained earnings of $310 reflecting the cumulative impact of adoption. The adoption did not materially impact the Company's results of operations orentity’s financial position, financial performance and cash flows. Further, ASC 815 requires qualitative disclosures that explain the Company’s objectives and strategies for using derivatives, as a result, comparisons between periods were not materially affected bywell as quantitative disclosures about the adoptionfair value of ASU 2016-13.and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

In January 2017,During the FASB issued ASU 2017-04, Simplifyingfirst quarter of fiscal year 2022, the TestCompany adopted the hedge accounting expedients related to probability and the assessments of effectiveness for Goodwill Impairment,future LIBOR-indexed cash flows to assume that the index upon which removesfuture hedged transactions will be based matches the second stepindex on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the goodwill impairment test that requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. This guidance is effective for interim and annual reporting periods beginning after December 15, 2019. The Company adopted ASU 2017-04 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements for fair value measurement by removing, modifying or adding certain disclosures. The new guidance is effective for annual periods beginning after December 15, 2019, and for interim periods within those fiscal years. The Company adopted ASU 2018-13 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amended guidance is effective for annual periods beginning after December 15, 2019, and for interim periods within those fiscal years. The Company adopted ASU 2018-15 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements Not Yet Effective

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies various aspects related to accounting for income taxes and eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating taxes during the quarters and the recognition of deferred tax liabilities for outside basis differences. The new guidance is effective for annual periods beginning after December 15, 2021, and for interim periods within those fiscal years. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships andmay apply other transactions affected by reference rate reform. ASU 2020-04 is currently effective and upon adoption may be applied prospectively to contract modifications made on or before December 31, 2022. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which clarifies certain provisions in Topic 848, if elected by an entity, to apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modifiedelections as a result of reference rate reform. The Company is currently assessing the impact that these standards will have on its consolidated financial statements.

In October 2020, the FASB issued ASU 2020-10, Codification Improvements - Disclosures. This ASU improves consistency by amending the codification to include all disclosure guidanceapplicable as additional changes in the appropriate disclosure sections and clarifies application of various provisions in the codification by amending and adding new headings, cross referencing to other guidance, and refining or correcting terminology. This ASU is effective for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.market occur.


1110
Table of Contents
3.    EARNINGS (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted net income (loss) per share:
Three Months Ended March 31,Nine Months Ended March 31, Three Months Ended September 30,
2021202020212020 20212020
Numerator:Numerator:Numerator:
Net income from continuing operations$34,254 $25,036 $25,624 $21,935 
Net (loss) income from discontinued operations0 (697)11,255 (105,581)
Net income (loss)$34,254 $24,339 $36,879 $(83,646)
Net income (loss) from continuing operationsNet income (loss) from continuing operations$19,411 $(10,781)
Net income from discontinued operationsNet income from discontinued operations— 11,266 
Net incomeNet income$19,411 $485 
Denominator:Denominator:Denominator:
Basic weighted average shares outstandingBasic weighted average shares outstanding99,831 104,032 100,502 104,192 Basic weighted average shares outstanding97,121 101,558 
Effect of dilutive stock options, unvested restricted stock and unvested restricted share unitsEffect of dilutive stock options, unvested restricted stock and unvested restricted share units1,765 305 883 297 Effect of dilutive stock options, unvested restricted stock and unvested restricted share units317 — 
Diluted weighted average shares outstandingDiluted weighted average shares outstanding101,596 104,337 101,385 104,489 Diluted weighted average shares outstanding97,438 101,558 
Basic net income (loss) per common share:Basic net income (loss) per common share:Basic net income (loss) per common share:
Continuing operationsContinuing operations$0.34 $0.24 $0.25 $0.21 Continuing operations$0.20 $(0.11)
Discontinued operationsDiscontinued operations0 (0.01)0.11 (1.01)Discontinued operations— 0.11 
Basic net income (loss) per common share$0.34 $0.23 $0.36 $(0.80)
Basic net income per common shareBasic net income per common share$0.20 $— 
Diluted net income (loss) per common share:Diluted net income (loss) per common share:Diluted net income (loss) per common share:
Continuing operationsContinuing operations$0.34 $0.24 $0.25 $0.21 Continuing operations$0.20 $(0.11)
Discontinued operationsDiscontinued operations0 (0.01)0.11 (1.01)Discontinued operations— 0.11 
Diluted net income (loss) per common share$0.34 $0.23 $0.36 $(0.80)
Diluted net income per common shareDiluted net income per common share$0.20 $— 



Basic net income (loss) per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units.

There were 4 and 512Anti-dilutive restricted stock awards and stock options excluded from our calculation of diluted net income (loss) per share for the three months ended March 31,September 30, 2021 and 2020, respectively, as such awards were anti-dilutive. Additionally, therede minimis. There were 23 and 2,6161,299 stock-based awards excluded for the three months ended March 31,September 30, 2021 and 2020, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods.period.

There were 182Due to our net loss from continuing operations in the three months ended September 30, 2020, all common stock equivalents such as stock options and 450unvested restricted stock awards and stock optionshave been excluded from the calculationcomputation of diluted net income (loss)loss per common share forbecause the nine months ended March 31, 2021 and March 31, 2020, respectively, as such awards were anti-dilutive. Additionally, there were 957 and 2,685 stock-based awards excluded foreffect would have been anti-dilutive to the nine months ended March 31, 2021 and 2020, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved duringcomputations in the respective periods.period.

Share Repurchase Program

OnIn June 21, 2017 and August 2021, the Company's Board of Directors authorized the repurchase of up to $250,000 and $300,000 of the Company’s issued and outstanding common stock.stock, respectively. Share repurchases under the 2021 authorization commenced in August 2021, after the 2017 authorization was fully utilized. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the three months ended March 31,September 30, 2021, the Company repurchased 2044,525 shares under the repurchase program for a total of $8,562,$175,597, excluding commissions, at an average price of $41.86$38.80 per share. During the nine months ended March 31,As of September 30, 2021, the Company had $206,811 of remaining authorization under the share repurchase program. During the three months ended September 30, 2020, the Company repurchased 2,4081,281 shares under the repurchase program for a total of $80,255,$42,027, excluding commissions, at an average price of $33.33$32.81 per share. As of March 31, 2021, the Company had $109,495 of remaining authorization under the share repurchase program.

4.     DISPOSITIONS

GG UniqueFiber®

1211
Table of Contents
4.     DISPOSITIONSOn June 28, 2021, the Company completed the divestiture of its crispbread crackers business, GG UniqueFiber® (“GG”) for total cash consideration of $336. The sale of GG is consistent with the Company’s transformation and portfolio simplification process. GG operated in Norway and was part of the Company’s International reportable segment. The Company deconsolidated the net assets of GG during the twelve months ended June 30, 2021, recognizing a pre-tax loss on sale of $3,753.

Dream® and WestSoy®

On April 15, 2021, the Company completed the divestiture of its North America non-dairy beverages business, consisting of the Dream® and WestSoy® brands, for total cash consideration of $33,000, subject to customary post-closing adjustments. The final purchase price was $31,320. The non-dairy beverage business was considered to be non-core within our broader North American business, and the sale aligns with the Company’s portfolio simplification process. The business operated out of the United States and Canada and was part of the Company’s North America reportable segment. The Company deconsolidated the net assets of the North American non-dairy beverage business during the twelve months ended June 30, 2021, recognizing a pre-tax gain on sale of $7,519.

Fruit

In August 2020, the Company's Board of Directors approved a plan to sell its prepared fresh fruit, fresh fruit drinks and fresh fruit desserts division ("Fruit"), primarily consisting of the Orchard House® Foods Limited business and associated brands. This decision supported the Company's overall strategy as the Fruit business did not align, and had limited synergies, with the rest of the Company's businesses. The sale was completed on January 13, 2021 (the "Closing Date") for total cash consideration of $38,547 of which $2,056 was due as of March 31, 2021 and was subsequently collected in April 2021.

Fruit operated in the United Kingdom and was included in the Company's International reportable segment, comprising 4.9% and 8.6% of the Company's net sales during the nine months ended March 31, 2021 and 2020, respectively. The Company determined that the held for sale criteria was metmet and classified the assets and liabilities of the Fruit business as held for sale as of September 30, 2020 and December 31, 2020, recognizing a pre-tax non-cash losslosses of $32,497 and $23,596, respectively, to reduce the carrying value to its estimated fair value less costs to sellsell. The sale was completed on January 13, 2021 for a total cash consideration of $56,093 during the six months ended December 31, 2020.

At the Closing Date, the assets and liabilities of the Fruit business consisted of the following:

January 13,
2021
ASSETS
Cash and cash equivalents$13,559 
Accounts receivable, less allowance for doubtful accounts14,057 
Inventories5,028 
Prepaid expenses and other current assets2,728 
Property, plant and equipment, net25,039 
Goodwill14,362 
Other intangible assets, net36,171 
Operating lease right-of-use assets5,623 
Allowance for reduction of assets held for sale(58,444)
Total assets$58,123
LIABILITIES
Accounts payable$14,428 
Accrued expenses and other current liabilities4,229 
Operating lease liabilities5,039 
Deferred tax liabilities7,298 
Other liabilities1,942 
Total liabilities$32,936

The Company deconsolidated the net assets of the Fruit business during the three months ended March 31, 2021,$38,547, recognizing a pre-tax loss on sale of $1,904.

Danival

The Company entered into a definitive stock purchase agreement on June 30, 2020 for the sale of its Danival business, a component of the International reportable segment, and the transaction closed on July 21, 2020. As of June 30, 2020, the Company determined the held for sale criteria was met, resulting in assets held for sale of $8,334 and related liabilities held for sale of $3,567 being included in the Company's Consolidated Balance Sheet as of June 30, 2020. These assets and liabilities were previously presented within Prepaid and other current assets and Accrued expenses and other liabilities, respectively, in the Form 10-K and have been reclassified to conform to current year presentation. The Company deconsolidated the net assets of the Danival business upon the closing of the sale during the quarter ended September 30, 2020.2020, recognizing a pre-tax gain on sale of $611.

13
Table of Contents
Discontinued Operations

Sale of Tilda Business

On August 27, 2019, the Company sold the entities comprising itsthe Tilda operating segment (the “Tilda Group Entities”)Entities and certain other assets of the Tilda business to Ebro Foods S.A. (the "Purchaser") for an aggregate price of $342,000 in cash, subject to customary post-closing adjustments based on the balance sheets of the Tilda business. The other assets sold in the transaction consisted of raw materials, consumables, packaging, and finished and unfinished goods related to the Tilda business held by other Company entities that are not Tilda Group Entities. In January 2020, the Company and the Purchaser agreed to fully resolve all matters relating to post-closing adjustments to the sale price, resulting in a final aggregate sale price of $341,800. The Company used the proceeds from the sale to pay down the remaining outstanding borrowings under its term loan and a portion of its revolving credit facility.

The Company also entered into certain ancillary agreements with the Purchaser and certain of the Tilda Group Entities in connection with the Sale and Purchase Agreement, including a transitional services agreement (the "TSA") pursuant to which the Company and the Purchaser provided transitional services to one another, and business transfer agreements pursuant to which the applicable Tilda Group Entities transferred certain non-Tilda assets and liabilities in India and the United Arab Emirates to subsidiaries of the Company to be formed in those countries. Additionally, the Company distributed certain Tilda products in the United States, Canada and Europe through the expiration of the TSA, which expired during the second quarter of fiscal 2020.

The disposition of the Tilda operating segment represented a strategic shift that had a major impact on the Company’s operations and financial results and has been accounted for as discontinued operations.

The following table presents the major classes of Tilda’s results within “NetNet income (loss) from discontinued operations, net of tax”tax in theour Consolidated Statements of Operations:
Three Months Ended March 31,Nine Months Ended March 31,
2021202020212020
Net sales$0 $0 $0 $30,399 
Cost of sales0 0 0 26,648 
Gross profit
0 0 0 3,751 
Selling, general and administrative expense0 0 0 5,185 
Other expense0 0 75 1,172 
Interest expense(1)
0 0 0 2,432 
Translation loss(2)
0 0 0 95,120 
Gain on sale of discontinued operations0 540 0 (9,630)
Net loss from discontinued operations before income taxes0 (540)(75)(90,528)
(Benefit) provision for income taxes(3)
0 (965)(11,320)12,900 
Net income (loss) from discontinued operations, net of tax$0 $425 $11,245 $(103,428)
Three Months Ended September 30,
2020
Net sales$— 
Cost of sales— 
Gross profit
— 
Other expense75 
Net loss from discontinued operations before income taxes(75)
Benefit for income taxes(1)
(11,331)
Net income from discontinued operations, net of tax$11,256 

(1) Interest expense was allocated to discontinued operations based on borrowings repaid with proceeds from the sale of Tilda.
(2) At the completion of the sale of Tilda, the Company reclassified $95,120 of related cumulative translation losses from Accumulated other comprehensive loss to discontinued operations, net of tax.
(3) Includes $11,320$11,331 of tax benefit related to the legal entity reorganization for the nine months ended March 31, 2021, as well as a tax benefit related to the gain on the sale of Tilda of $750 and tax expense of $14,500 for the three and nine months ended March 31, 2020, respectively.September 30, 2020.

There were 0no assets or liabilities from discontinued operations associated with Tilda as of March 31,September 30, 2021 or June 30, 2020.2021.

Sale of Hain Pure Protein Reportable Segment

In March 2018, the Company’s Board of Directors approved a plan to sell all of the operations of the HPPC operating segment, which included the Plainville Farms and FreeBird businesses, and the EK Holdings, Inc. (“Empire Kosher” or “Empire”) operating segment, which were reported in the aggregate as the Hain Pure Protein reportable segment. Collectively, these dispositions represented a
1412
Table of Contents
strategic shift that had a major impact on the Company’s operations and financial results and have been accounted for as discontinued operations.

The Company is presenting the operating results and cash flows of HPPC within discontinued operationsCompany's dispositions are described in more detail in Note 5, Dispositions, in the nine months ended March 31, 2021 andNotes to the Consolidated Financial Statements in the comparable prior year period.

Form 10-K.
Sale of Plainville Farms Business ("Plainville")

On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for Plainville (a component of HPPC), which included $25,000 in cash to the purchaser, for a nominal purchase price. In addition, the purchaser assumed the current liabilities of Plainville as of the closing date. As a condition to consummating the sale, the Company entered into a Contingent Funding and Earnout Agreement, which provided for the issuance by the Company of an irrevocable stand-by letter of credit (the “Letter of Credit”) of $10,000 which expired nineteen months after issuance, during the first quarter of fiscal 2021. The Company was entitled to receive an earnout not to exceed, in the aggregate, 120% of the maximum amount that the purchaser draws on the Letter of Credit at any point from the date of issuance through the expiration of the Letter of Credit. Earnout payments are based on a specified percentage of annual free cash flow achieved for all fiscal years ending on or prior to June 30, 2026. If a subsequent change in control of Plainville occurs prior to June 30, 2026, the purchaser will pay the Company 120% of the difference between the amount drawn on the Letter of Credit less the sum of all earnout payments made prior to such time up to the net proceeds received by the purchaser. At March 31, 2021, the Company had not recorded an asset associated with the earnout.

Sale of HPPC and Empire Kosher

On June 28, 2019, the Company completed the sale of the remainder of HPPC and EK Holdings, which included the FreeBird and Empire Kosher businesses. The purchase price, net of estimated customary adjustments based on the closing balance sheet of HPPC, was $77,714. The Company used the proceeds from the sale to pay down a portion of its outstanding borrowings under its term loan. The following table presents the major classes of Hain Pure Protein’s results within “Net loss (income) from discontinued operations, net of tax” in the Consolidated Statements of Operations:

Three Months Ended March 31,Nine Months Ended March 31,
2021202020212020
Net sales$0 $0 $0 $0 
Cost of sales0 0 0 0 
Gross profit (loss)0 0 0 0 
Selling, general and administrative expense0 0 0 0 
Asset impairments0 0 0 0 
Other income0 0 (10)0 
Loss on sale of discontinued operations(1)
0 1,781 0 3,205 
Net (loss) income from discontinued operations before income taxes0 (1,781)10 (3,205)
Benefit for income taxes0 (659)0 (1,052)
Net (loss) income from discontinued operations, net of tax$0 $(1,122)$10 $(2,153)

(1) Primarily relates to preliminary closing balance sheet adjustments.

There were 0 assets or liabilities from discontinued operations associated with HPPC at March 31, 2021 or June 30, 2020.
15
Table of Contents

5.    INVENTORIES

Inventories consisted of the following:
March 31,
2021		June 30,
2020		September 30,
2021		June 30,
2021
Finished goodsFinished goods$213,411 $158,162 Finished goods$180,604 $187,884 
Raw materials, work-in-progress and packagingRaw materials, work-in-progress and packaging100,487 90,008 Raw materials, work-in-progress and packaging99,572 97,526 
$313,898 $248,170 $280,176 $285,410 

At each period end, inventory is reviewed to ensure that it is recorded at the lower of cost or net realizable value. Inventory write-downs forDuring the three months ended March 31,September 30, 2021 and March 31, 2020, werethe Company recorded inventory write-downs of $0 and $1,362204, respectively. Inventory write-downs for the nine months ended March 31, 2021 and March 31, 2020 were $311 and $5,278, respectively.

6.    PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:
March 31,
2021		June 30,
2020		September 30,
2021		June 30,
2021
LandLand$14,561 $13,866 Land$13,252 $13,666 
Buildings and improvementsBuildings and improvements73,240 74,325 Buildings and improvements55,199 58,143 
Machinery and equipmentMachinery and equipment317,270 288,466 Machinery and equipment306,275 306,811 
Computer hardware and softwareComputer hardware and software61,661 60,391 Computer hardware and software66,076 65,132 
Furniture and fixturesFurniture and fixtures23,272 20,044 Furniture and fixtures23,874 23,546 
Leasehold improvementsLeasehold improvements39,009 40,876 Leasehold improvements56,371 54,360 
Construction in progressConstruction in progress34,980 16,489 Construction in progress23,246 21,633 
563,993 514,457 544,293 543,291 
Less: accumulated depreciation and amortizationLess: accumulated depreciation and amortization252,651 225,201 Less: accumulated depreciation and amortization231,867 230,514 
$311,342 $289,256 $312,426 $312,777 

Depreciation expense for the three months ended March 31,September 30, 2021 and 2020 was $9,1187,408 and $7,789, respectively. Depreciation expense for the nine months ended March 31, 2021 and 2020 was $26,302 and $23,518,$9,703, respectively.

As of December 31, 2020,A facility in the Company reclassified $24,971 of Property, plant and equipment, net to AssetsUnited Kingdom was held for sale as part of June 30, 2021 with a net carrying amount of 1,874. Additionally, a facility in the United States was held for sale accounting related to the Company's Fruit business (see Note 4, Dispositions, for more information related to the held for sale assets). There was an impairment chargeas of $1,333 recorded during the nine months ended March 31,September 30, 2021 and 0 impairment charge recorded during the nine months ended March 31, 2020.


with a net carrying amount of $1,768.
1613
Table of Contents
7.    LEASES
The Company leases office space, warehouse and distribution facilities, manufacturing equipment and vehicles primarily in North America and Europe. The Company determines if an arrangement is or contains a lease at inception. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company’s lease agreements generally do not contain residual value guarantees or material restrictive covenants. A limited number of lease agreements include rental payments adjusted periodically for inflation.
Some of the Company’s leases contain variable lease payments, which are expensed as incurred unless those payments are based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease commencement and included in the measurement of the lease liability; thereafter, changes to lease payments due to rate or index changes are recorded as variable lease expense in the period incurred. The Company does not have any related party leases, and sublease transactions are de minimis.

14
Table of Contents
The components of lease expenses for the three and nine months ended March 31,September 30, 2021 and 2020 were as follows:
Three Months Ended September 30,
20212020
Operating lease expenses$3,752 $3,956 
Finance lease expenses70 185 
Variable lease expenses403 866 
Short-term lease expenses1,365 913 
Total lease expenses$5,590 $5,920 

Three Months EndedNine Months Ended
March 31, 2021March 31, 2020March 31, 2021March 31, 2020
Operating lease expenses$4,129 $4,545 $12,290 $14,034 
Finance lease expenses72 272 318 761 
Variable lease expenses247 633 1,204 1,873 
Short-term lease expenses458 490 1,701 1,349 
Total lease expenses$4,906 $5,940 $15,513 $18,017 
Additional information related to leases is as follows:
Three Months Ended September 30,
20212020
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$3,745 $4,359 
Operating cash flows from finance leases$5 $3 
Financing cash flows from finance leases$60 $85 
ROU assets obtained in exchange for lease obligations:
Operating leases$319 $7,766 
Finance leases$— $15 
Weighted average remaining lease term:
Operating leases9.6 years10.1 years
Finance leases4.1 years2.1 years
Weighted average discount rate:
Operating leases3.3 %3.0 %
Finance leases4.2 %2.6 %

Supplemental balance sheet information related to leases was as follows:
LeasesLeasesClassificationMarch 31, 2021June 30, 2020LeasesClassificationSeptember 30, 2021June 30, 2021
AssetsAssetsAssets
Operating lease ROU assets, netOperating lease ROU assets, netOperating lease right-of-use assets$90,130 $88,165 Operating lease ROU assets, netOperating lease right-of-use assets, net$88,387 $92,010 
Finance lease ROU assets, netFinance lease ROU assets, netProperty, plant and equipment, net615 691 Finance lease ROU assets, netProperty, plant and equipment, net469 547 
Total leased assetsTotal leased assets$90,745 $88,856 Total leased assets$88,856 $92,557 
LiabilitiesLiabilitiesLiabilities
CurrentCurrentCurrent
OperatingOperatingAccrued expenses and other current liabilities$11,086 $12,338 OperatingAccrued expenses and other current liabilities$11,216 $10,870 
FinanceFinanceCurrent portion of long-term debt245 308 FinanceCurrent portion of long-term debt195 229 
Non-currentNon-currentNon-current
OperatingOperatingOperating lease liabilities, noncurrent portion83,564 82,962 OperatingOperating lease liabilities, noncurrent portion82,176 85,929 
FinanceFinanceLong-term debt, less current portion376 316 FinanceLong-term debt, less current portion283 326 
Total lease liabilitiesTotal lease liabilities$95,271 $95,924 Total lease liabilities$93,870 $97,354 


1715
Table of Contents
Additional information related to leases is as follows:
Nine Months Ended
March 31, 2021March 31, 2020
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$12,954 $12,856 
Operating cash flows from finance leases$13 $18 
Financing cash flows from finance leases$285 $372 
ROU assets obtained in exchange for lease obligations (a):
Operating leases$18,349 $94,389 
Finance leases$671 $1,092 
Weighted average remaining lease term:
Operating leases10.0 years8.4 years
Finance leases4.1 years2.3 years
Weighted average discount rate:
Operating leases3.2 %2.7 %
Finance leases3.9 %2.9 %

(a) ROU assets obtained in exchange for lease obligations includes leases which commenced, were modified or terminated. The balance for the nine months ended March 31, 2020 also included $87,414 relating to the impact of the adoption of ASU 2016-02 effective July 1, 2019.

Maturities of lease liabilities as of March 31,September 30, 2021 were as follows:
Fiscal YearOperating leasesFinance leasesTotal
2021 (remainder of year)$2,665 $71 $2,736 
202214,358 246 14,604 
202313,596 133 13,729 
202411,878 51 11,929 
202510,663 51 10,714 
Thereafter60,084 127 60,211 
Total lease payments113,244 679 113,923 
Less: Imputed interest18,594 58 18,652 
Total lease liabilities$94,650 $621 $95,271 

Maturities of lease liabilities as of June 30, 2020 were as follows:
Fiscal YearOperating leasesFinance leasesTotal
2021$14,781 $308 $15,089 
202213,798 205 14,003 
202312,833 95 12,928 
202410,941 18 10,959 
20259,521 6 9,527 
Thereafter51,545 0 51,545 
Total lease payments113,419 632 114,051 
Less: Imputed interest18,119 8 18,127 
Total lease liabilities$95,300 $624 $95,924 

Fiscal YearOperating leasesFinance leasesTotal
2022 (remainder of year)$10,094 $163 $10,257 
202314,499 133 14,632 
202412,712 51 12,763 
202511,313 51 11,364 
202610,741 51 10,792 
Thereafter52,096 76 52,172 
Total lease payments111,455 525 111,980 
Less: Imputed interest18,063 47 18,110 
Total lease liabilities$93,392 $478 $93,870 
1816
Table of Contents

8.    GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table provides the changes in the carrying value of goodwill by reportable segment:
North AmericaInternationalTotal
Balance as of June 30, 2020 (a)
$606,055 $255,903 $861,958 
  Reclassification of goodwill to assets held for sale0 (14,362)(14,362)
  Translation and other adjustments, net2,642 27,484 30,127 
Balance as of March 31, 2021 (a)
$608,697 $269,025 $877,723 
(a) The total carrying value of goodwill is reflected net of $134,277 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment, $29,219 related to the Company’s Europe operating segment and $7,700 related to the Company’s former Hain Ventures operating segment, whose goodwill and accumulated impairment charges were reallocated within the North America reportable segment to the United States and Canada operating segments on a relative fair value basis.

As of September 30 and December 31, 2020, Fruit, a part of the International reportable segment, was classified as held for sale and therefore, goodwill associated with Fruit was reclassified to Assets held for sale within the Consolidated Balance Sheet as of December 31, 2020. See Note 4, Dispositions, for more information. Fruit was a component of the Company's Hain Daniels reporting unit. The decision to sell the business was a triggering event requiring an interim goodwill impairment test for the Hain Daniels reporting unit. No impairment was recorded during the nine months ended March 31, 2021.

North AmericaInternationalTotal
Balance as of June 30, 2021$600,812 $270,255 $871,067 
  Translation and other adjustments, net(777)(6,942)(7,719)
Balance as of September 30, 2021$600,035 $263,313 $863,348 
Other Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:
March 31,
2021		June 30,
2020
Non-amortized intangible assets:
Trademarks and tradenames (a)
$280,690 $278,103 
Amortized intangible assets:
Other intangibles148,422 184,854 
Less: accumulated amortization(104,321)(116,495)
Net carrying amount$324,791 $346,462 

(a) The gross carrying value of trademarks and tradenames is reflected net of $93,273 of accumulated impairment charges as of both March 31, 2021 and June 30, 2020.
September 30,
2021		June 30,
2021
Non-amortized intangible assets:
Trademarks and tradenames$270,084 $273,471 
Amortized intangible assets:
Other intangibles143,884 146,856 
Less: accumulated amortization(105,380)(105,432)
Net carrying amount$308,588 $314,895 

There were no events or circumstances that warranted an interim impairment test for indefinite-lived intangible assets during the ninethree months ended March 31,September 30, 2021 or 2020.

During the nine months ended March 31, 2021, the Company reclassified certain of its indefinite-lived intangible assets consisting of trademarks and tradenames to definite-lived intangible assets and began amortization of these assets. The annualized amortization expense of these assets is $914 and will amortize over an estimated useful life of 10 years.

Amortized intangible assets, which are deemed to have a finite life, primarily consist of customer relationships and certain trademarks and tradenames and are amortized over their estimated useful lives of 35 to 25 years. Amortization expense included in continuing operations was as follows:

19
Table of Contents
Three Months Ended March 31,Nine Months Ended March 31,
 2021202020212020
Amortization of acquired intangibles$2,145 $3,174 $6,771 $9,446 
Three Months Ended September 30,
 20212020
Amortization of acquired intangibles$2,095 $2,433 

2017
Table of Contents
9.    DEBT AND BORROWINGS

Debt and borrowings consisted of the following:
March 31,
2021		June 30,
2020
Revolving credit facility$255,000 $280,000 
Other borrowings1,239 2,774 
256,239 282,774 
Short-term borrowings and current portion of long-term debt699 1,656 
Long-term debt, less current portion$255,540 $281,118 
September 30,
2021		June 30,
2021
Revolving credit facility$344,969 $230,000 
Other borrowings780 1,022 
345,749 231,022 
Short-term borrowings and current portion of long-term debt335 530 
Long-term debt, less current portion$345,414 $230,492 

Credit Agreement

On February 6, 2018, the Company entered into the Third Amended and Restated Credit Agreement (as amended, the(the “Credit Agreement”). The Credit Agreement provides for a $1,000,000 revolving credit facility through February 6, 2023 and providedprovides for a $300,000 term loan. Under the Credit Agreement, the revolving credit facility may be increased by an additional uncommitted $400,000, provided certain conditions are met.

Borrowings under the Credit Agreement may be used to provide working capital, finance capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other lawful corporate purposes. The Credit Agreement provides for multicurrency borrowings in Euros Pounds Sterling and Canadian dollars as well as other currencies which may be designated. In addition, certain wholly-owned foreign subsidiaries of the Company may be designated as co-borrowers. The Credit Agreement contains restrictive covenants, which are usual and customary for facilities of its type, and include, with specified exceptions, limitations on the Company’s ability to engage in certain business activities, incur debt, have liens, make capital expenditures, pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans. The Credit Agreement also requires the Company to satisfy certain financial covenants. Obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company. As of March 31,September 30, 2021, there were $255,000$344,969 of borrowings outstanding under the revolving credit facility and $6,394 letters of credit outstanding under the Credit Agreement. In the nine months ended March 31, 2020, the Company used the proceeds from the sale of Tilda, net of transaction costs, to prepay the entire principal amount of term loan outstanding under its credit facility and to partially pay down its revolving credit facility. In connection with the prepayment, the Company wrote off unamortized deferred debt issuance costs of $973, recorded in Interest and other financing expense, net in the Consolidated Statements of Operations.

On May 8, 2019, the Company entered into the Third Amendment to the Third Amended and Restated Credit Agreement (the “Amended Credit Agreement”), whereby, among other things, its allowable consolidated leverage ratio (as defined in the Credit Agreement) and interest coverage ratio (as defined in the Credit Agreement) were adjusted. The Company’s allowable consolidated leverage ratio is no more than 3.75 to 1.0 from March 31, 2021on September 30, 2020 and thereafter. Additionally, the Company’s required consolidated interest coverage ratio wasis no less than 3.75 to 1 through March 31, 2021 and no less than 4.0 to 1 thereafter.

The Amended Credit Agreement also required that the Company and the subsidiary guarantors enter into a Security and Pledge Agreement pursuant to which all of the obligations under the Amended Credit Agreement are secured by liens on assets of the Company and its material domestic subsidiaries, including stock of each of their direct subsidiaries and intellectual property, subject to agreed upon exceptions.

As of March 31,September 30, 2021, $738,606648,637 was available under the Amended Credit Agreement, and the Company was in compliance with all associated covenants, as amended by the Amended Credit Agreement.

The Amended Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in the Credit Agreement, plus a rate ranging from 0.875%0.88% to 2.50% per annum; or (b) the Base Rate, as defined in the Credit Agreement, plus a rate ranging from 0.00% to 1.50% per annum, the relevant rate being the Applicable Rate. The Applicable Rate will be determined in accordance with a leverage-based pricing grid, as set forth in the Amended Credit Agreement. Swing Line loans and Global Swing Line loans denominated in U.S. dollars will bear interest at the Base Rate plus the Applicable Rate, and Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight Eurocurrency Rate for loans denominated in such currency plus the Applicable Rate. The weighted average interest rate on outstanding borrowings under the Amended Credit Agreement at March 31,September 30, 2021 was 1.11%1.08%. Additionally, the Amended Credit Agreement contains a Commitment Fee, as defined in the Amended Credit Agreement, on the amount unused under the Amended Credit Agreement ranging from 0.20% to 0.45% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.
21
18
Table of Contents
10.    INCOME TAXES

In general, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability on the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.

The effective income tax rate from continuing operations was an expense of 25.7%18.6% and a benefit of 66.7%589.2% for the three months ended March 31,September 30, 2021 and 2020, respectively. TheLower effective income tax rate from continuing operations was an expense of 55.5% and a benefit of 72.8%relative to our statutory tax rates for the nine months ended March 31, 2021current quarter is mainly due to the reversal of uncertain tax position accruals based on filing and 2020, respectively. The effective income tax rates from continuing operations for the nine months ended March 31, 2021 were impactedapproval of certain elections by various discrete items including the tax impact of the Fruit impairment and disposal, the enacted change in the United Kingdom's corporate income tax rate to 19% and a legal entity reorganization completed during the quarter ended September 30, 2020.authorities. In addition, thethe effective income tax rates from continuing operations for the three and nine months ended March 31,September 30, 2021 and 2020 were negatively impacted by provisions in the Tax Cuts and Jobs Act (the "Tax Act"), primarily related to Global Intangible Low Taxed Income ("GILTI") and limitations on the deductibility of executive compensation. Furthermore, the effective income tax rate from continuing operations for the three months ended September 30, 2020 was negatively impacted by various discrete items including the tax impact of the United Kingdom Fruit business reserve, the legal entity reorganization, and the UK rate change. The effective income tax rates in each period were also impacted by the geographical mix of earnings and state valuation allowance.

Through the nine months ended The income tax expense (benefit) from disconMarch 31, 2021, the Company received $53,817 including $1,317 of interest from the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") tax loss carryback refund claims.

There were 0 discontinuedtinued operations was $0 for the three months ended September 30, 2021March 31, 2021 and an, while the income tax benefit from discontinued operations of $11,320 for the nine months ended March 31, 2021. The income tax from discontinued operations was a benefit of $1,624 and expense of $11,848$11,331 for the three and nine months ended March 31, 2020, respectively.September 30, 2020. The benefit for income tax for the ninethree months ended March 31, 2021September 30, 2020 was impacted by a legal entity reorganization. The expense for income taxes for the nine months ended March 31, 2020 was impacted by $14,500 of tax related to the tax gain on the sale of the Tilda entities.
22

Table of Contents
11.     ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table presents the changes in accumulated other comprehensive loss ("AOCL"):
Three Months Ended March 31,Nine Months Ended March 31,
2021202020212020
Foreign currency translation adjustments:
Other comprehensive income (loss) before reclassifications (1)
$1,672 $(52,315)$80,491 $(42,602)
Amounts reclassified into income (2)
14,725 0 15,906 95,120 
Deferred gains (losses) on cash flow hedging instruments:
Amount of gain (loss) gain recognized in AOCL on derivatives (3)
1,168 0(621)0 
Amount of (loss) gain reclassified from AOCL into (expense) income (3)
(914)109 995 83 
Deferred gains (losses) on net investment hedging instruments:
Amount of gain (loss) recognized in AOCL on derivatives (3)
3,107 0 (2,763)0 
Amount of loss reclassified from AOCL into expense (3)
(97)0 (298)0 
Net change in AOCL$19,661 $(52,206)$93,710 $52,601 
Three Months Ended September 30,
20212020
Foreign currency translation adjustments:
Other comprehensive (loss) income before reclassifications$(22,805)$32,776 
Amounts reclassified into income (1)
— 1,181 
Deferred gains (losses) on cash flow hedging instruments:
    Other comprehensive gain (loss) before reclassifications535 (883)
Amounts reclassified into (expense) income (2)
(500)923 
Deferred gains (losses) on net investment hedging instruments:
Other comprehensive gain (loss) before reclassifications1,910 (2,890)
Amounts reclassified into expense (2)
(103)(102)
Net change in AOCL$(20,963)$31,005 

(1) Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were a net gain of $0 and $453 for the three months ended March 31, 2021 and 2020, respectively. Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were a net loss of $0 and $703 for the nine months ended March 31, 2021 and 2020, respectively.
(2) Foreign currency translation gains or losses of foreign subsidiaries related to divested businesses are reclassified into income once the liquidation of the respective foreign subsidiaries is substantially complete. AtDuring the completion of the sales of Danival and Fruit, the Company reclassified $15,906 of translation losses from accumulated comprehensive loss to the Company's results of operations. At the completion of the sale of Tilda,three months ended September 30, 2020, the Company reclassified $95,1201,181 of translation losses from accumulated comprehensive lossAOCL to Other income, net on the Company’s resultsConsolidated Statement of discontinued operations.Operations.
(3)(2) See Note 15, Derivatives and Hedging Activities, for the amounts reclassified into income for deferred gains (losses) on cash flow hedging instruments recorded in the Consolidated Statements of Operations in the three and nine months ended March 31,September 30, 2021 and 2020.

2319
Table of Contents
12.    STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

The Company has 1a stockholder approved plan, the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan (the "2002 Plan"), under which the Company’s officers, senior management, other key employees, consultants and directors may be granted equity-based awards. The Company also grants shares under its 2019 Equity Inducement Award Program (the "2019 Inducement Program") to induce selected individuals to become employees of the Company. The 2002 Plan and 2019 Inducement Program are collectively referred to as the "Stock Award Plans."Plans". In conjunction with the Stock Award Plans, the Company maintains a long-term incentive program (the “LTI Program”) that provides for performance and market equity awards that can be earned over defined performance periods. The Company's plans are described in Note 15,14, Stock-Based Compensation and Incentive Performance Plans, in the Notes to the Consolidated Financial Statements in the Form 10-K.

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Operations for stock-based compensation plans were as follows:
Three Months Ended March 31,Nine Months Ended March 31, Three Months Ended September 30,
2021202020212020 20212020
Selling, general and administrative expenseSelling, general and administrative expense$3,698 $3,761 $11,888 $9,581 Selling, general and administrative expense$4,287 $4,367 
Discontinued operations0 0 0 544 
Total compensation cost recognized for stock-based compensation plans$3,698 $3,761 $11,888 $10,125 
Related income tax benefitRelated income tax benefit$441 $630 $1,447 $1,300 Related income tax benefit$273 $807 

Restricted Stock

Awards of restricted stock are either restricted stock awards ("RSAs") or restricted stock units ("RSUs") that are issued at no cost to the recipient. Performance-based or market-based RSUs are issued in the form of performance share units ("PSUs"). A summary of the restricted stock activity (including all RSAs, RSUs and PSUs) for the ninethree months ended March 31,September 30, 2021 is as follows:
Number of Shares
and Units
Weighted
Average Grant
Date Fair 
Value (per share)
Non-vested RSAs, RSUs and PSUs outstanding at June 30, 20202,049 $15.85 
Granted206 $35.45 
Vested(333)$23.58 
Forfeited(109)$16.50 
Non-vested RSAs, RSUs and PSUs outstanding at March 31, 20211,813 $16.59 
Number of Shares
and Units
Weighted
Average Grant
Date Fair 
Value (per share)
Non-vested RSAs, RSUs and PSUs outstanding at June 30, 20211,780 $16.55 
Granted12 $39.81 
Vested(61)$21.78 
Forfeited(103)$15.43 
Non-vested RSAs, RSUs and PSUs outstanding at September 30, 20211,628 $16.53 

At March 31,September 30, 2021 and June 30, 2020,2021, the table above includes a total of 1,3891,299 and 1,3841,382 shares (including an inducement grant of 350 shares made to the Company'sour CEO as previously disclosed), respectively, that represent the target number of shares that may be earned based on pre-defined market conditions andunder non-vested performance equity awards that are eligible to vest ranging from 0up to 300% of target. Vested shares during the current period include a total of 2013 shares under the 2018-2020 LTIP that actuallywhich vested at 150% of target based on achievement of the maximum relative TSR target.certain performance-based metrics being met.

Nine Months Ended March 31,Three Months Ended September 30,
2021202020212020
Fair value of RSAs, RSUs and PSUs grantedFair value of RSAs, RSUs and PSUs granted$7,298 $16,634 Fair value of RSAs, RSUs and PSUs granted$478 $4,398 
Fair value of shares vestedFair value of shares vested$12,266 $5,848 Fair value of shares vested$2,522 $1,056 
Tax benefit recognized from restricted shares vestingTax benefit recognized from restricted shares vesting$1,786 $(102)Tax benefit recognized from restricted shares vesting$246 $152 

At March 31,September 30, 2021, there was $13,091$5,169 of unrecognized stock-based compensation expense related to non-vested restricted stock awards which is expected to be recognized over a weighted average period of 1.21.1 years.

Subsequent to the quarter end, 1,299 shares underlying PSUs under the 2019-2021 LTI Program vested on November 6, 2021 at 100% of target based on achieving the target goal for total shareholder return.

24
20
Table of Contents
13.    INVESTMENTS

On October 27, 2015, the Company acquired a minority equity interest in Chop’t Creative Salad Company LLC, predecessor to Chop't Holdings,Founders Table Restaurant Group, LLC (“Chop’t”Founders Table”). Chop’tFounders Table develops and operates fast-casual, fresh salad restaurants in the Northeast and Mid-Atlantic United States. The investment is being accounted for as an equity method investment due to the Company’s representation on the Board of Directors of Chop’t.Founders Table. At March 31,September 30, 2021 and June 30, 2020,2021, the carrying value of the Company’s investment in Chop’t was $11,09810,161 and $12,793,$10,699, respectively, and is included in the Consolidated Balance Sheets as a component of Investments and joint ventures.

The Company also holds the following investments: (a) Hutchison Hain Organic Holdings Limited a joint venture(“HHO”) with Hutchison China Meditech Ltd., a joint venture accounted for under the equity method of accounting, (b) Hain Future Natural Products Private Ltd., a joint venture with Future Consumer Ltd, a joint venture accounted for under the equity method of accounting, and (c) Yeo Hiap Seng Limited, infor which the Company holds a less than 1% equity ownership interest. The carrying value of these combined investments was $6,2446,557 and $4,6466,218 as of March 31,September 30, 2021 and June 30, 2020,2021, respectively, and is included in the Consolidated Balance Sheets as a component of Investments and joint ventures.

25
Table of Contents
14.    FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

•Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
•Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
•Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents assets and liabilities measured at fair value on a recurring basis as of March 31,September 30, 2021: 
Total
Quoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Derivative financial instruments$682 $0 $682 $0 
Equity investment618 618 0 0 
Total$1,300 $618 $682 $0 
Liabilities:
Derivative financial instruments10,831 0 10,831 0 
Total$10,831 $0 $10,831 $0 
Total
Quoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Derivative financial instruments746 — 746 — 
Equity investment590 590 — — 
Total$1,336 $590 $746 $— 
Liabilities:
Derivative financial instruments$9,007 $— $9,007 $— 
Total$9,007 $— $9,007 $— 

21
Table of Contents
The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2020:
Total
Quoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Cash equivalents$7 $7 $0 $0 
Derivative financial instruments1,014 0 1,014 0 
Equity investment562 562 0 0 
Total$1,583 $569 $1,014 $0 
Liabilities:
Derivative financial instruments6,405 0 6,405 0 
Total$6,405 $0 $6,405 $0 
2021:
Total
Quoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Derivative financial instruments699 — 699 — 
Equity investment646 646 — — 
Total$1,345 $646 $699 $— 
Liabilities:
Derivative financial instruments$11,968 $— $11,968 $— 
Total$11,968 $— $11,968 $— 

The equity investment consists of the Company’s less than 1% investment in Yeo Hiap Seng Limited, a food and beverage manufacturer and distributor based in Singapore. Fair value is measured using the market approach based on quoted prices. The Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices.

There were no transfers of financial instruments between the three levels of fair value hierarchy during the ninethree months ended March 31,September 30, 2021 or 2020.

The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s debt approximates fair value due to the debt bearing fluctuating market interest rates (see Note 9, Debt and Borrowings).

26
Table of Contents
In addition to the instruments named above, the Company makes fair value measurements in connection with its assets and liabilities classified as held for sale, as these balances represent the estimated fair value, less costs to sell (See Note 4, Dispositions). The Company also makes fair value measurements in connection with its interim and annual goodwill and tradename impairment testing. These measurements fall into Level 3 of the fair value hierarchy (See Note 8, Goodwill and Other Intangible Assets).

Derivative Instruments

The Company uses interest rate swaps to manage its interest rate risk and cross-currency swaps and foreign currency exchange contracts to manage its exposure to fluctuations in foreign currency exchange rates. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves.

In accordance with the provisions of ASC 820, Fair Value Measurements, the Company incorporates credit valuation adjustments to appropriately reflect both the Company’s nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of the Company’s derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. The Company has also determined that the significance of the impact of the credit valuation adjustments made to its derivative contracts, which determination was based on the fair value of each individual contract, was not significant to the overall valuation. As a result, all of the derivatives held as of March 31,September 30, 2021 and June 30, 20202021 were classified as Level 2 of the fair value hierarchy.

The fair value estimates presented in the fair value hierarchy tables above are based on information available to management as of March 31,September 30, 2021 and June 30, 2020.2021. These estimates are not necessarily indicative of the amounts we could ultimately realize.
22
Table of Contents

15.    DERIVATIVES AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s receivables and borrowings.

Certain of the Company’s foreign operations expose the Company to fluctuations of foreign exchange rates. These fluctuations may impact the value of the Company’s cash receipts and payments in terms of the Company’s functional currency. The Company enters into derivative financial instruments to protect the value or fix the amount of certain assets and liabilities in terms of its functional currency, the U.S. dollar.

Accordingly, the Company uses derivative financial instruments to manage and mitigate such risks. The Company does not use derivatives for speculative or trading purposes.


27
Table of Contents
Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During the three and nine months ended March 31,September 30, 2021, such derivatives were used to hedge the variable cash flows associated with existing variable rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in AOCL related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable rate debt. During the remaining threenine months of fiscal 2021,2022, the Company estimates that an additional $174$283 will be reclassified as an increase to interest expense.

As of March 31,September 30, 2021, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:

Interest Rate DerivativeNumber of InstrumentsNotional Amount
Interest Rate Swap4$230,000

Cash Flow Hedges of Foreign Exchange Risk

The Company is exposed to fluctuations in various foreign currencies against its functional currency, the U.S. Dollar. The Company uses foreign currency derivatives including cross-currency swaps to manage its exposure to fluctuations in the USD-EUR exchange rates. Cross-currency swaps involve exchanging fixed-rate interest payments for fixed-rate interest receipts, both of which will occur at the USD-EUR forward exchange rates in effect upon entering into the instrument. The Company, at times, also uses forward contracts to manage its exposure to fluctuations in the GBP-EUR exchange rates. The Company designates these derivatives as cash flow hedges of foreign exchange risks.

For derivatives designated and that qualify as cash flow hedges of foreign exchange risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified in the period(s) during which the hedged transaction affects earnings within the same income statement line item as the earnings effect of the hedged transaction. During the remaining threenine months of fiscal 2021,2022, the Company estimates that an additional $82$127 relating to cross-currency swaps will be reclassified as an increasea decrease to interest income.expense.

23
Table of Contents
As of March 31,September 30, 2021, the Company had the following outstanding foreign currency derivatives that were used to hedge its foreign exchange risks:

Foreign Currency DerivativeForeign Currency DerivativeNumber of InstrumentsNotional SoldNotional PurchasedForeign Currency DerivativeNumber of InstrumentsNotional SoldNotional Purchased
Cross-currency swapCross-currency swap1€24,700$26,775Cross-currency swap1€24,700$26,775
Foreign currency forward contractForeign currency forward contract6£5,142€6,000

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in its European foreign entities and their exposure to the Euro. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in the foreign exchange rate on its foreign investment in Europe. Currency forward agreements involve fixing the USD-EUR exchange rate for delivery of a specified amount of foreign currency on a specified date. The currency forward agreements are typically cash settled in U.S. Dollars for their fair value at or close to their settlement date. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency fixed-rate payments over the life of the agreement.

For derivatives designated as net investment hedges, the gain or loss on the derivative is reported in AOCL as part of the cumulative translation adjustment. Amounts are reclassified out of AOCL into earnings when the hedged net investment is either sold or substantially liquidated.
28
Table of Contents

As of March 31,September 30, 2021, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:

Foreign Currency DerivativeNumber of InstrumentsNotional SoldNotional Purchased
Cross-currency swap2€76,969$83,225

Non-Designated Hedges

Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements and/or the Company has not elected to apply hedge accounting. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings.

As of March 31,September 30, 2021 the Company had 0no outstanding derivatives that were not designated as hedges in qualifying hedging relationships.

Designated Hedges

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of March 31,September 30, 2021:

Asset DerivativesLiability Derivatives
Balance Sheet LocationFair ValueBalance Sheet LocationFair Value
Derivatives designated as hedging instruments:
Interest rate swapsPrepaid expenses and other current assets$9 Accrued expenses and other current liabilities / Other noncurrent liabilities$313 
Cross-currency swapsPrepaid expenses and other current assets673 Other noncurrent liabilities10,518 
Total derivatives designated as hedging instruments$682 $10,831 


2924
Table of Contents
Asset DerivativesLiability Derivatives
Balance Sheet LocationFair ValueBalance Sheet LocationFair Value
Derivatives designated as hedging instruments:
Interest rate swapsPrepaid expenses and other current assets$49 Accrued expenses and other current liabilities / Other noncurrent liabilities$330 
Cross-currency swapsPrepaid expenses and other current assets697 Other noncurrent liabilities8,677 
Total derivatives designated as hedging instruments$746 $9,007 


The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of June 30, 2020:2021:

Asset DerivativesLiability DerivativesAsset DerivativesLiability Derivatives
Balance Sheet LocationFair ValueBalance Sheet LocationFair ValueBalance Sheet LocationFair ValueBalance Sheet LocationFair Value
Derivatives designated as hedging instruments:Derivatives designated as hedging instruments:Derivatives designated as hedging instruments:
Interest rate swapsInterest rate swapsPrepaid expenses and other current assets$0 Accrued expenses and other current liabilities / Other noncurrent liabilities$856 Interest rate swapsPrepaid expenses and other current assets$43 Accrued expenses and other current liabilities / Other noncurrent liabilities$312 
Cross-currency swapsCross-currency swapsPrepaid expenses and other current assets746 Other noncurrent liabilities5,475 Cross-currency swapsPrepaid expenses and other current assets656 Other noncurrent liabilities11,656 
Foreign currency forward contractsPrepaid expenses and other current assets75 Other noncurrent liabilities0 
Total derivatives designated as hedging instrumentsTotal derivatives designated as hedging instruments$821 $6,331 Total derivatives designated as hedging instruments$699 $11,968 
Derivatives not designated as hedging instruments:
Foreign currency forward contractsPrepaid expenses and other current assets193 Accrued expenses and other current liabilities74 
Total derivative instruments$1,014 $6,405 

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL as of the three months ended March 31,September 30, 2021 and 2020:

Derivatives in Cash Flow Hedging RelationshipsDerivatives in Cash Flow Hedging RelationshipsAmount of Gain (Loss) Recognized in OCI on DerivativesLocation of Gain (Loss) Reclassified from AOCL into IncomeAmount of Gain (Loss) Reclassified from AOCL into IncomeDerivatives in Cash Flow Hedging RelationshipsAmount of Gain (Loss) Recognized in AOCL on DerivativesLocation of Gain (Loss) Reclassified from AOCL into IncomeAmount of Gain (Loss) Reclassified from AOCL into Income
Three Months Ended March 31,Three Months Ended March 31,Three Months Ended September 30,Three Months Ended September 30,
20212020202120202021202020212020
Interest rate swapsInterest rate swaps$217 $0 Interest and other financing expense, net$(82)$0 Interest rate swaps$(117)$61 Interest and other financing expense, net$(104)$(58)
Cross-currency swapsCross-currency swaps1,262 0 Interest and other financing expense, net / Other expense (income), net1,239 0 Cross-currency swaps776 (1,177)Interest and other financing expense, net / Other expense (income), net738 (1,183)
Foreign currency forward contractsForeign currency forward contracts0 134 Cost of sales0 $0 Foreign currency forward contracts19 (2)Cost of sales— 73 
TotalTotal$1,479 $134 $1,157 $0 Total$678 $(1,118)$634 $(1,168)

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL as of the nine months ended March 31, 2021 and 2020:
3025
Table of Contents
Derivatives in Cash Flow Hedging RelationshipsAmount of Gain (Loss) Recognized in OCI on DerivativesLocation of Gain (Loss) Reclassified from AOCL into IncomeAmount of Gain (Loss) Reclassified from AOCL into Income
Nine Months Ended March 31,Nine Months Ended March 31,
2021202020212020
Interest rate swaps$341 $0 Interest and other financing expense, net$(212)$0 
Cross-currency swaps(1,124)0 Interest and other financing expense, net / Other expense (income), net(1,120)0 
Foreign currency forward contracts(2)128 Cost of sales73 26 
Total$(785)$128 $(1,259)$26 

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the three months endedas of March 31,September 30, 2021 and 2020:

Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
Three Months Ended March 31, 2021Three Months Ended March 31, 2020
Cost of salesInterest and other financing expense, netOther expense/income, netCost of salesInterest and other financing expense, netOther expense/income, net
The effects of cash flow hedging:
(Loss) gain on cash flow hedging relationships
Interest rate swaps
Amount of (loss) reclassified from AOCL into expense$0 $(82)$0 $0 $0 $0 
Cross-currency swaps
Amount of gain reclassified from AOCL into income$— $39 $1,200 $— $— $— 
Foreign currency forward contracts
Amount of gain reclassified from AOCL into income$— $— $— $— $— $— 

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the nine months ended of March 31, 2021 and 2020:

31
Table of Contents
Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
Nine Months Ended March 31, 2021Nine Months Ended March 31, 2020
Cost of salesInterest and other financing expense, netOther expense (income), netCost of salesInterest and other financing expense, netOther expense (income), net
The effects of cash flow hedging:
(Loss) gain on cash flow hedging relationships
Interest rate swaps
Amount of (loss) gain reclassified from AOCL into expense$0 $(212)$0 $0 $0 $0 
Cross-currency swaps
Amount of gain (loss) reclassified from AOCL into income (expense)$— $120 $(1,240)$— $— $— 
Foreign currency forward contracts
Amount of gain reclassified from AOCL into income$73 $— $— $26 $— $— 
Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
Three Months Ended September 30, 2021Three Months Ended September 30, 2020
Cost of salesInterest and other financing expense, netOther expense (income), netCost of salesInterest and other financing expense, netOther expense (income), net
The effects of cash flow hedging:
Gain (loss) on cash flow hedging relationships
Interest rate swaps
Amount of loss reclassified from AOCL into income$— $(104)$— $— $(58)$— 
Cross-currency swaps
Amount of gain (loss) reclassified from AOCL into income$— $41 $697 $— $41 $(1,224)
Foreign currency forward contracts
Amount of gain reclassified from AOCL into income$— $— $— $73 $— $— 

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the three months ended March 31,as of September 30, 2021 and 2020:

Derivatives in Net Investment Hedging RelationshipsAmount of Gain (Loss) Recognized in OCI on DerivativesLocation of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)
Three Months Ended March 31,Three Months Ended March 31,
2021202020212020
Cross-currency swaps$3,933 $0 Interest and other financing expense, net$123 $0 

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the nine months ended March 31, 2021 and 2020:

Derivatives in Net Investment Hedging RelationshipsDerivatives in Net Investment Hedging RelationshipsAmount of Gain (Loss) Recognized in OCI on DerivativesLocation of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)Derivatives in Net Investment Hedging RelationshipsAmount of Gain (Loss) Recognized in AOCL on DerivativesLocation of Gain (Loss) Recognized in Income on DerivativesAmount of Gain (Loss) Recognized in Income on Derivatives
Nine Months Ended March 31,Nine Months Ended March 31,Three Months Ended September 30,Three Months Ended September 30,
20212020202120202021202020212020
Cross-currency swapsCross-currency swaps$(3,498)$0 Interest and other financing expense, net$377 $0 Cross-currency swaps$2,417 $(3,658)Interest and other financing expense, net$130 $129 

Non-Designated Hedges

The following table presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments on the Consolidated Statements Operations for the three months ended March 31,as of September 30, 2021 and 2020:

32
Table of Contents
Derivatives Not Designated as Hedging InstrumentsLocation of Gain (Loss) Recognized in Income on DerivativeAmount of Gain (Loss) Recognized in Income on Derivatives
Three Months Ended March 31,
20212020
Foreign currency forward contractsOther (income) expense, net$0 $(336)

The following table presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments on the Consolidated Statements Operations for the nine months ended March 31, 2021 and 2020:

Derivatives Not Designated as Hedging InstrumentsDerivatives Not Designated as Hedging InstrumentsLocation of Gain (Loss) Recognized in Income on DerivativeAmount of Gain (Loss) Recognized in Income on DerivativesDerivatives Not Designated as Hedging InstrumentsLocation of Gain (Loss) Recognized in Income on DerivativeAmount of Gain (Loss) Recognized in Income on Derivatives
Nine Months Ended March 31,Three Months Ended September 30,
2021202020212020
Foreign currency forward contractsForeign currency forward contractsOther (income) expense, net$(399)$(505)Foreign currency forward contractsOther expense (income), net$— $124 

Credit-Risk-Related Contingent Features

The Company has agreements with each of its derivative counterparties that contain a provision providing that upon certain defaults by the Company on any of its indebtedness, the Company could also be declared in default on its derivative obligations.

26
Table of Contents
16.    TERMINATION BENEFITS RELATED TO PRODUCTIVITY AND TRANSFORMATION INITIATIVES

As a part of the ongoing productivity and transformation initiatives related to the Company’s strategic objective to expand profit margins and cash flow, the Company initiated a reduction in workforce at targeted locations in the United States as well as at certain locations internationally. The reduction in workforce associated with these initiatives are expected to result in charges throughout fiscal 2021.2022.

The following table displays the termination benefits and personnel realignment activities and liability balances relating to the reduction in workforce for the period ended as of March 31,September 30, 2021:

Balance at June 30, 2020Charges (reversals)Amounts PaidForeign Currency Translation & Other AdjustmentsBalance at March 31, 2021
Termination benefits and personnel realignment$11,541 $3,488 $(10,051)$59 $5,037 
Balance at June 30, 2021ChargesAmounts PaidForeign Currency Translation & Other AdjustmentsBalance at September 30, 2021
Termination benefits and personnel realignment$4,448 $285 $(2,539)$(12)$2,182 

The liability balance as of March 31,September 30, 2021 and June 30, 20202021 is included within Accrued expenses and other current liabilities on the Company’s Consolidated Balance Sheets.

17.    COMMITMENTS AND CONTINGENCIES

Securities Class Actions Filed in Federal Court

On August 17, 2016, 3 securities class action complaints were filed in the Eastern District of New York against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The 3 complaints are: (1) Flora v. The Hain Celestial Group, Inc., et al. (the “Flora Complaint”); (2) Lynn v. The Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). On June 5, 2017, the court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola voluntarily dismissed his claims without prejudice to his ability to
33
Table of Contents
participate in the Consolidated Securities Action as an absent class member. The Co-Lead Plaintiffs in the Consolidated Securities Action filed a Consolidated Amended Complaint on August 4, 2017 and a Corrected Consolidated Amended Complaint on September 7, 2017 on behalf of a purported class consisting of all persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the “Amended Complaint”). The Amended Complaint named as defendants the Company and certain of its former officers (collectively, “Defendants”) and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss the Amended Complaint on October 3, 2017 which the Court granted on March 29, 2019, dismissing the case in its entirety, without prejudice to replead. Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the “Second Amended Complaint”). The Second Amended Complaint again named as defendants the Company and certain of its former officers and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegations similar to those in the Amended Complaint, including materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss the Second Amended Complaint on June 20, 2019. Co-Lead Plaintiffs filed an opposition on August 5, 2019, and Defendants submitted a reply on September 3, 2019. On April 6, 2020, the Court granted Defendants' motion to dismiss the Second Amended Complaint in its entirety, with prejudice. Co-Lead Plaintiffs filed a notice of appeal on May 5, 2020 indicating their intent to appeal the Court’s decision dismissing the Second Amended Complaint to the United States Court of Appeals for the Second Circuit. Co-Lead Plaintiffs filed their appellate brief on August 18, 2020. Defendants filed their opposition brief on November 17, 2020, and Plaintiffs filed their reply brief on December 8, 2020. Accordingly, Co-Lead Plaintiffs’ appeal is fully briefed. Oral argument has not yet been scheduled.took place on September 27, 2021. The parties await a decision.

Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court

On April 19, 2017 and April 26, 2017, 2 class action and stockholder derivative complaints were filed in the Eastern District of New York against the former Board of Directors and certain former officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva
27
Table of Contents
Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.

On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the former Board of Directors and certain former officers of the Company. The complaint alleged that the Company’s former directors and certain former officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleged that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August 9, 2017, the Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff (the “Merenstein Complaint”).

On August 10, 2017, the court granted the parties' stipulation to consolidate the Barnes Complaint, the Silva Complaint and the Merenstein Complaint under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”) and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel, with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. On September 14, 2017, a related complaint was filed under the caption Oliver v. Berke, et al. (the “Oliver Complaint”), and on October 6, 2017, the Oliver Complaint was consolidated with the Consolidated Stockholder Class and Derivative Action. The Plaintiffs filed their consolidated amended complaint under seal on October 26, 2017. On December 20, 2017, the parties agreed to stay Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through and including 30 days after a decision was rendered on the motion to dismiss the Amended Complaint in the Consolidated Securities Action, described above.

On March 29, 2019, the Court in the Consolidated Securities Action granted Defendants’ motion, dismissing the Amended Complaint in its entirety, without prejudice to replead. Co-Lead Plaintiffs in the Consolidated Securities Action filed the Second Amended Complaint on May 6, 2019. The parties to the Consolidated Stockholder Class and Derivative Action agreed to continue the stay of Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through 30 days after a decision on Defendants' motion to dismiss the Second Amended Complaint in the Consolidated Securities Action.

On April 6, 2020, the Court granted Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action, with prejudice. Pursuant to the terms of the stay, Defendants in the Consolidated Stockholder Class and Derivative Action had until May 6, 2020 to answer, move, or otherwise respond to the complaint in this matter. This deadline
34
Table of Contents
was extended, and Defendants moved to dismiss the Consolidated Stockholder Class and Derivative Action Complaint on June 23, 2020, with Plaintiffs’ opposition due August 7, 2020.

On July 24, 2020, Plaintiffs made a stockholder litigation demand on the current Board containing overlapping factual allegations to those set forth in the Consolidated Stockholder Class and Derivative Action. On August 10, 2020, the Court vacated the briefing schedule on Defendants’ pending motion to dismiss in order to give the Board of Directors time to consider the demand. On each of September 8 and October 8, 2020, the Court extended its stay of any applicable deadlines for 30 days to give the Board of Directors additional time to complete its evaluation of the demand. On November 3, 2020, Plaintiffs were informed that the Board of Directors had finished investigating and resolved, among other things, that the demand should be rejected. On November 6, 2020, Plaintiffs and Defendants notified the Court that Plaintiffs were evaluating the rejection of the demand, sought certain additional information and were assessing next steps, and requested that the Court extend the stay for an additional 30 days, to on or around December 7, 2020. Since that time, Plaintiffs and Defendants have filed a number of joint status reports, requesting that the Court stay applicable deadlines to allow for the production of certain materials by the Board of Directors for review by Plaintiffs. The current stay ordered by the Court is set to expire on May 7,December 30, 2021.

Baby Food Litigation

Since the beginningFebruary 2021, a large number of the quarter ended March 31, 2021, approximately 25 pending consumer class actions have been brought against the Company alleging that the Company’s Earth’s Best baby food products (the “Products”) contain unsafe and undisclosed levels of various naturally-occurring heavy metals, namely lead, arsenic, cadmium and mercury. TheseThere are currently 29 active lawsuits, which generally allege that the Company violated various state consumer protection laws and make other state and common law warranty and unjust enrichment claims related to the alleged failure to disclose the presence of these metals and that consumers would have allegedly either not purchased the Products or would have paid less for them had the Company made adequate disclosures. These putative class actions seek to certify a nationwide class of consumers as well as various state subclasses. One of the consumer class actions (Jenna Johnson(Kathryn Gavula, et. al. v. Beech NutBeech-Nut Nutrition Co., et. al.) filed in the U.S. District Court for the District of Kansas alsoOregon alleges civil RICO claims that the Company conspiredviolated the Racketeer Influenced and Corrupt Organizations Act (“RICO”) by conspiring with other baby food manufacturers to conceal the presence of these heavy metals in our respective products. These actions have been filed against all of the major baby food manufacturers in federal courts across the country, althoughcountry. The U.S. Judicial
28
Table of Contents
Panel on Multidistrict Litigation (“JPML”) declined a request to centralize all of the consumer class action lawsuits against all of the baby food manufacturers into a single multidistrict proceeding, and the vast majority of cases against the Company have now been filedtransferred and consolidated in the U.S. District Court for the Eastern District of New York.York, In re Hain Celestial Heavy Metals Baby Food Litigation, Case No. 2:21-cv-678. One consumer class action is pending in New York Supreme Court, Nassau County. The Company has moved to stay or transfer this case to the consolidated proceeding in the Eastern District of New York and that motion is pending. The Company denies the allegations in these lawsuits and contends that its baby foods are safe and properly labeled.

The claims raised in these lawsuits were brought in the wake of a highly-publicizedhighly publicized report issued by the U.S. House of Representatives Subcommittee on Economic and Consumer Policy on Oversight and Reform, dated February 4, 2021 (the “House Report”), addressing the presence of heavy metals in baby foods made by certain manufacturers, including the Company. Since the publishing of the House Report, the Company has also received information requests with respect to the advertising and quality of its baby foods from certain governmental authorities, as such authorities investigate the claims made in the House Report. The Company is fully cooperating with these requests and is providing documents and other requested information.

On March 8, 2021, the plaintiffs The Company has been named in one of the lawsuits (Albano v. Hain Celestial Group) filed a petition before the U.S. Judicial Panel on Multidistrict Litigation (“JPML”) seeking to centralize all of the consumer classcivil government enforcement action, lawsuits against all of the baby food manufacturers into single multidistrict proceeding in the U.S. District Court for the Eastern DistrictState of New York. On April 13, 2021,Mexico ex rel. Balderas v. Nurture, Inc., et al., which was filed by the New Mexico Attorney General against the Company and several other manufacturers based on the alleged presence of heavy metals in their baby food products. The Company and several other manufacturers as well as numerous plaintiffs inhave moved to dismiss the other lawsuits, filed responsesNew Mexico Attorney General’s lawsuit, and that motion to the Albano petition. The JPML has set a hearing and oral argument on the petition for May 27, 2021. The JPMLdismiss is expected to decide by early June 2021 as to whether these lawsuits will be consolidated before a single court and, if so, where.currently pending.

In addition to the consumer class actions discussed above, since the beginning of the quarter ended March 31, 2021, the Company has also beenis currently named in approximately 6 pending4 lawsuits in state and federal courts alleging some form of personal injury from the ingestion of the Company'sCompany’s Products, purportedly due to unsafe and undisclosed levels of various naturally occurring heavy metals. NaN of these cases make individuallawsuits name multiple plaintiffs alleging claims of injury,physical injuries. These lawsuits generally allege injuries related to neurological development disorders such as autism and attention deficit hyperactivity disorder. NaN of the lawsuits seek relief on behalf of a class of allegedly injured persons, including damages for medical monitoring for potential injuries that may develop later. The Company denies that its Products led to any of these injuries and will defend the cases vigorously.

Other

In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company
35
Table of Contents
believes the probable final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial position, cash flows or liquidity.


18.    SEGMENT INFORMATION

In accordance with ASC 280, Segment Reporting, the Company,Our organization structure consist of 2 geographic based on economic similarity, defines its operating segments as the following 5 segments: the United States, United Kingdom (Hain Daniels), Ella's Kitchen UK, Europe and Canada. Similarly, under the same guidance, the Company operates under 2 reportable segments: North America and International. Our North America reportable segment consists of the United States and Canada as operating segments. Our International reportable segment is comprised of 3 operating segments: United Kingdom, Ella’s Kitchen UK and Europe. This structure is in line with how our Chief Operating Decision Maker (“CODM”) assesses our performance and allocates resources.

NetWe use segment net sales and operating income are the primary measures used by the Company’s chief operating decision maker ("CODM") to evaluate segment operating performance and to decide howallocate resources. We believe these measures are most relevant in order to allocate resources to segments. The CODM is the Company’s CEO. Expenses related toanalyze segment results and trends. Segment operating income excludes certain centralized administration functions thatgeneral corporate expenses (which are not specifically related to an operating segment are included in Corporatea component of selling, general and Other expenses. Corporateadministrative expenses), impairment and Other expenses are comprised mainly of the compensation andacquisition related expenses, of certain of the Company’s senior executive officersrestructuring, integration and other selected employees who perform duties related to the entire enterprise, as well as expenses for certain professional fees, facilities and other items which benefit the Company as a whole. Additionally, certain Productivity and transformation costs are included in Corporate and Other. Expenses that are managed centrally, but can be attributed to a segment, such as employee benefits and certain facility costs, are allocated based on reasonable allocation methods. Information about total assets by segment is not disclosed because such information is not reported to or used by the Company’s CODM for purposes of assessing segment performance or allocating resources.charges.

3629
Table of Contents

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.
Three Months Ended March 31,Nine Months Ended March 31,
2021202020212020
Net Sales:
North America$287,500 $320,440 $850,780 $872,834 
International205,104 232,857 668,869 669,323 
$492,604 $553,297 $1,519,649 $1,542,157 
Operating Income (Loss):
North America$39,492 $28,873 $105,188 $64,067 
International26,774 18,660 8,144 40,666 
66,266 47,533 113,332 104,733 
Corporate and Other (a)
(16,689)(28,398)(47,518)(73,952)
$49,577 $19,135 $65,814 $30,781 
Three Months Ended September 30,
20212020
Net Sales:
North America$265,525 $280,668 
International189,378 217,959 
$454,903 $498,627 
Operating Income (Loss):
North America$16,842 $33,256 
International24,069 (15,889)
40,911 17,367 
Corporate and Other (a)
(15,364)(14,087)
$25,547 $3,280 

(a) In addition to general Corporate and Other expenses as described above, for the three months ended March 31,September 30, 2021, Corporate and Other included $2,804includes $2,057 of Productivity and transformation costs. For the three months ended March 31,September 30, 2020, Corporate and Other included $5,572includes $803 of Productivity and transformation costs and tradename impairment charges of $7,650 (related to North America).

For the nine months ended March 31, 2021, Corporate and Other included $6,343 of Productivity and transformation costs. For the nine months ended March 31, 2020, Corporate and Other included $26,142 of Productivity and transformation costs and tradename impairment charges of $9,539 ($4,007 related to North America; $5,532 related to International), partially offset by a benefit of $2,962 of proceeds from insurance claim.

The Company's net sales by product category are as follows:

Three Months Ended March 31,Nine Months Ended March 31,Three Months Ended September 30,
202120202021202020212020
GroceryGrocery$322,107 $373,723 $1,030,544 $1,081,497 Grocery$301,553 $343,749 
SnacksSnacks79,768 79,252 235,641 227,925 Snacks85,892 81,159 
Personal CarePersonal Care50,446 66,950 144,057 138,880 Personal Care40,366 48,982 
TeaTea40,283 33,372 109,407 93,855 Tea27,092 24,737 
TotalTotal$492,604 $553,297 $1,519,649 $1,542,157 Total$454,903 $498,627 

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiaries, were as follows:
Three Months Ended March 31,Nine Months Ended March 31,
2021202020212020
United States$251,887 $279,534 $735,947 $758,759 
United Kingdom139,094 169,024 475,739 501,619 
All Other101,623 104,739 307,963 281,779 
Total$492,604 $553,297 $1,519,649 $1,542,157 
Three Months Ended September 30,
20212020
United States$233,487 $239,717 
United Kingdom123,748 157,169 
All Other97,668 101,741 
Total$454,903 $498,627 


3730
Table of Contents
The Company’s long-lived assets, which primarily represent net property, plant and equipment, operating lease right-of-use assets and noncurrent other assets by geographic area were as follows:
March 31,
2021		June 30,
2020		September 30,
2021		June 30,
2021
United StatesUnited States$165,516 $146,633 United States$146,858 $148,950 
United KingdomUnited Kingdom148,929 149,943 United Kingdom144,200 142,973 
All OtherAll Other109,290 105,303 All Other109,755 112,864 
TotalTotal$423,735 $401,879 Total$400,813 $404,787 

19.    RELATED PARTY TRANSACTIONS

On April 15, 2021, the Company completed the divestiture of its North America non-dairy beverages brands, Dream® and WestSoy®, for $33,000 subject to customary post-closing adjustments.$31,320. The purchaser in this transaction was SunOpta Inc. (“SunOpta”). The non-employee chair of the Company's Board of Directors is also the chair of the board of SunOpta.

SunOpta is also one of the Company’s suppliers, for which the Company incurs expenses in the ordinary course of business. The Company incurred expenses of $3,649$220 and $2,513$4,810 in the three months ended March 31,September 30, 2021 and 2020, respectively, to SunOpta and its affiliated entities. For the nine months ended March 31, 2021 and 2020, the Company incurred expenses of $12,806 and $13,106, respectively, to SunOpta and its affiliated entities.

A former member of the Company's Board of Directors is a partner in a law firm which provides legal services to the Company. The Company incurred expenses of $259 and $1,141 in the three months ended March 31, 2021 and 2020, respectively, and $1,476 and $3,629 in the nine months ended March 31, 2021 and 2020, respectively, to the law firmsupplier and affiliated entities. The director resigned from the Board in February 2020.


3831
Table of Contents
Item 2.        Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Consolidated Financial Statements and the related Notes thereto for the period ended March 31,September 30, 2021 contained in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended June 30, 2020.2021. Forward looking statements in this Form 10-Q are qualified by the cautionary statement included in this Form 10-Q under the sub-heading “Cautionary Note Regarding Forward Looking Information”“Forward-Looking Statements” in the introduction of this Form 10-Q.

Overview

The Hain Celestial Group, Inc., a Delaware corporation (collectively along with its subsidiaries, the “Company,” and herein referred to as “Hain Celestial,” “we,” “us” andor “our”), was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — To Create and Inspire A Healthier Way of LifeTM andtenet. The Company continues to be thea leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores in over 7580 countries worldwide. The Company operates under two reportable segments: North America and International.

The Company manufactures, markets, distributes and sells organic and natural products under brand names providing consumers with the opportunity to lead A Healthier Way of Life®. Hain Celestial is a leader in many organic and natural products categories, with many recognized brands in the various market categories it serves, including Celestial Seasonings®, Clarks™, Cully & Sully®, Earth’s Best®, Ella’s Kitchen®, Farmhouse Fare™, Frank Cooper’s®, GG UniqueFiber®, Gale’sGale's®, Garden of Eatin’Eatin'®, Hain Pure Foods®, Hartley’s®, Health Valley®, Imagine®, Joya®, Lima®, Linda McCartney's®™ (under license), MaraNatha®, Natumi®, New Covent Garden Soup Co.®, Robertson’s®, Rose's® (under license), Sensible Portions®, Spectrum®, Sun-Pat®, Terra®, The Greek Gods®, William’s™, Yorkshire Provender® and Yves Veggie Cuisine®. The Company’s personal care products are marketed under the Alba Botanica®, Avalon Organics®, Earth’s Best®, JASON®, Live Clean®, One Step® and Queen Helene® brands.

The Company continues to executeSince fiscal 2019, we have been executing the four key pillars of its strategy: our strategy—(1) simplify itsour portfolio; (2) strengthen itsour capabilities; (3) expand profit margins and cash flow;flow; and (4) reinvigorate profitable toplinetop line growth—which we refer to as Hain 2.0. This strategy, which is on schedule to be completed ahead of our planned timeline, has laid the foundation for Hain 3.0, our vision and strategy for the next several years, which is about building a global healthy food and beverage company with industry-leading top line growth. We believe Hain 3.0 positions us as an advantaged and differentiated company, as compared to others in the food industry for several reasons:

•we are singularly focused on health and wellness,
•The Company has executed this strategy,we are a global company in high-growth categories with opportunities for expansion in existing and new channels and geographies,
•we have unique and advantaged brands with strong points of difference, and
•given our size, small wins can drive material incremental growth.

We have re-segmented the brand portfolio with a focusmore global view to where we have the most growth potential. As a result, we are migrating from a strategy focused ondiscontinuing uneconomic investment, realigning resources to coincide with brand importance, reducing unproductive stock-keeping units (“SKUs”) and brands and reassessing current pricing architecture. As part of this initiative, the Company reviewed its product portfolio within rejuvenating North America behind a construct of “Get Bigger" and divided it into “Get Bigger” and “Get"Get Better” brand categories.categories to one that focuses on growing global brands in categories where we think we have the most potential. The categories we have identified are called Turbocharge Growth, Targeted Investment, and Fuel:

•The Company’s “Get Bigger”Turbocharge Growth brands represent its strongest brands with higher margins, which compete in categories with strong growth potential. The Company has concentrated its investment in marketing, innovation and other resources to prioritize spending for theseare leading-share brands in an effort to reinvigorate profitable topline growth, optimize assortmentvery high-growth categories. The Turbocharge Growth brands are made up of plant-based meat and increase share of distribution.

non-dairy beverages as well as snacks. Our meat and dairy alternatives are concentrated outside the United States, while the snacks businesses include brands both within the United States and in International.
•The Company’s “Get Better”Targeted Investment brands are themade up of leading-share brands in whichlower-growth categories. To date, we have demonstrated our ability to drive market share and reinvigorate these categories, and we expect that we can continue to do this in the Companyfuture. The Targeted Investment brands are made up of tea, baby, yogurt, and personal care. In contrast with Hain 2.0, baby is primarily focused on simplificationnow one of our growth focus areas, due to its strong brands, scale, profitability, and expansion of profit margin. Some of thesegrowth prospects.
•The Fuel brands have historically been low margin, non-strategicare stable brands that added complexitywill be leveraged to fuel investment in the Turbocharge Growth and Targeted Investment categories. Fuel brands are made up of premium pantry brands with minimal benefit to the Company’s operations.

In addition,scale, in categories such as part of the Company’s overall strategy, the Company may seek to dispose of businessessoup, cooking oils and brands that are less profitable or are otherwise less of a strategic fit within its core portfolio. During fiscal 2019, for example, the Company divested its Hain Pure Protein reportable segment and its WestSoy® tofu, seitan and tempeh businesses. In fiscal 2020, the Company divested its Tilda business and its Arrowhead Mills®, SunSpire®, Europe's Best®, Casbah®, Rudi’s Gluten-Free Bakery™, Rudi’s Organic Bakery® and Fountain of Truth™ brands. In fiscal 2021, the Company divested Danival®, along with its U.K. fruit business ("Fruit"), primarily consisting of the Orchard House® Foods Limited business and associated brands, and in April 2021, the Company completed the sale of both WestSoy® and Dream®.

COVID-19

The COVID-19 pandemic continues to create challenging and unprecedented conditions, and we continue our commitment to supporting the global response to the crisis. Various policies and initiatives have been implemented by governments, organizations and individuals to reduce the global transmission of COVID-19.

nut butters.
3932
Table of Contents
Although thereAdditionally, as part of Hain 3.0, we will continue to simplify our brand portfolio as we continue to identify brands that are effective vaccines for COVID-19declining and have low margins. The Simplify brands are subscale declining businesses that have been approvedlimited long-term potential for use, it is uncertain when the rate of vaccinationsCompany, and therefore will allow a return to a more normal economic activity and business operations. Access to vaccines and vaccination rates vary greatly by country. In addition, recent lockdowns in Europe,be managed for profit until they are potentially divested, likely over the presence of new variants and efficacy of existing vaccines against new variants pose additional uncertainty about the duration and extentcourse of the impact fromnext several years. Acquisitions are expected to play a role in Hain 3.0 and part of our capital allocation strategy is focused on actively looking for targets in the COVID-19 pandemic.market. As we continue to simplify and stabilize the organization and consolidate sales into fewer priority categories, we are well-positioned and expect to make targeted acquisitions supported by our borrowing capacity to help us further strengthen our position in those categories.

Employee and Consumer Health and Safety PrecautionsCOVID-19

From the outset of the pandemic, our first priority has been the well-being of our employees and consumers. We continue to consistently meet or exceed government guidelines for addressing the health and safety of our employees, including global travel restrictions, prohibitions against visitors, social distancing requirements, the use of thermal temperature scanners, and the provision of personal protective equipment to our employees. We have continued the use of certain technology to allow many of our office-based employees to work from home effectively.

Manufacturing Facilities and Supply Chain Challenges

Shelter-in-place and social distancing behaviors, which are being mandated or encouraged by governments and practiced by businesses and individuals, continue to create challenges for our manufacturing employees. We have safety protocols in place that consistently meet or exceed government guidelines for addressing the health and safety of our employees, and we have successfully implemented contingency plans overseen by crisis management teams to monitor the evolving needs of our business.

To date, there have been some disruptions to our supply chain network, including labor availability and the supply of our ingredients, packaging or other sourced materials. It is possible that additional disruptions could occur if the COVID-19 pandemic continues to impact markets around the world. We are also working closely with our contract manufacturers, distributors, and other external business partners to minimize the potential impact on our business.

Additionally, we continue to consolidate product shipping orders to more efficiently meet increased customer and consumer demand.

Consumer Demand

Shelter-in-place and social distancing behaviors have resulted in increased overall demand for our products, most notably in our grocery, snacks, tea and certain personal care product categories. Other product offerings have been adversely impacted due to changed consumer behavior and priorities, such as sun care products in the early stages of the pandemic.

While we have experienced a net increase in the overall demand for our products during the COVID-19 pandemic, the continued duration of that increased demand environment is uncertain. Additionally, deteriorating economic conditions arising from the COVID-19 pandemic could adversely affect future demand for our products. Factors such as increased unemployment, decreases in disposable income and declines in consumer confidence could cause a decrease in demand for our overall product set, particularly higher priced products.

Our Financial Position

The COVID-19 pandemic has resulted in a net increase in overall demand for our products. Accordingly,The impact was particularly pronounced during the early stages of the pandemic as consumers reacted to date,stay-at-home measures and the uncertainty of the pandemic. In particular, our financial position hasnet sales during the third quarter of fiscal 2020 through the second quarter of fiscal 2021 benefited from pandemic-driven demand. The pandemic-driven demand for our products has subsided as effective vaccines have become available, governments have eased safety measures and consumer purchasing behaviors have started to return to pre-pandemic norms. As a result, net sales were lower in the COVID-19 pandemic, albeitthird and fourth quarters of fiscal 2021 compared to the third and fourth quarters of fiscal 2020, respectively. Further, net sales in the first quarter of fiscal 2022 were lower than our net sales during the first quarter of fiscal 2021 as a limited extent. We finance our operations primarily with the cash flows we generate from our operations and from borrowings available to us under our Third Amended and Restated Credit Agreement (as amended, the “Amended Credit Agreement”). Asresult of March 31, 2021, we had borrowing capacity of $738.6 million availablenormalizing consumer demand, among other factors as described more fully below under the Amended Credit Agreement.heading "Comparison of Three Months Ended September 30, 2021 to Three Months Ended September 30, 2020."

Business PrioritiesThe pandemic and the measures being taken by governments, businesses and consumers to limit the spread of COVID-19 have led to operational challenges in our business and may result in broader and longer-term challenges and uncertainty that we will need to manage successfully. Such challenges include but are not limited to:

While•manufacturing, supply chain and logistics challenges resulting from health and safety precautions among our employees and the currentgeneral population as well as macroeconomic factors resulting from the pandemic, including labor market shortages;
•an uncertain future demand environment has caused us to delay certain planned innovationas a result of changing consumer behaviors amid uncertain economic conditions; and productivity initiatives,
•increased costs of operating our business strategy of simplifyingand managing our portfolio and reinvigorating profitable sales growth remains unchanged.

Financial Impact on Third Parties and Equity Investments

Deteriorating economic conditions could jeopardize the viability of some third parties and our business relationships with them and could cause us to incur losses or increased costs in our dealings with those third parties. We have taken measures to
40
Table of Contents
minimize the impact of hardships faced by individual business partners, including by identifying secondary sources of supply and manufacturing capabilities.

Productivity and Transformation Costs

In fiscal 2019, the Company announced a strategy that includes as one of its key pillars identifying areas of cost savings and operating efficiencies to expand profit margins and cash flow. As part of this overall strategy and the key pillar of realizing savings and efficiencies, during fiscal 2020, the Company began the integration of its United States and Canada operations in alignment with the North America reportable segment structure. In addition, during fiscal 2021, the Company initiated cost reduction programs for its international businesses in the United Kingdom and Europe. The Company will carry out additional productivity initiatives under this strategy in fiscal 2021.

Productivity and transformation costs include costs, such as consulting and severance costs, relating to streamlining the Company’s manufacturing plants, co-packers and supply chain eliminating served categories or brands within those categories, and product rationalization initiatives which are aimed at eliminating slow moving SKUs.during a global pandemic.

Discontinued Operations

On August 27, 2019, the Company and Ebro Foods S.A. (the “Purchaser”) entered into, and consummated the transactions contemplated by, an agreement relating to the sale and purchase of the entities comprising the Company’s Tilda Group Entitiesoperating segment and certain other assets.

On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for the Plainville Farms business, a component of the Company’s Hain Pure Protein Corporation (“HPPC”) operating segment. On June 28, 2019, the Company completed the sale of the remainder of HPPC and Empire Kosher which included the FreeBird and Empire Kosher businesses. TheseThe Company's dispositions were undertaken to reduce complexityare described in the Company’s operations and simplify the Company’s brand portfolio,more detail in addition to allowing additional flexibility to focus on opportunities for growth and innovation in the Company’s more profitable and faster growing core businesses. Collectively, these dispositions were reported in the aggregate as the Hain Pure Protein reportable segment.

These dispositions represented strategic shifts that had a major impact on the Company’s operations and financial results, and therefore, the Company is presenting the operating results and cash flows of the Tilda operating segment and the Hain Pure Protein reportable segment within discontinued operations in the current and prior periods. See Note 4,5, Dispositions, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of thisthe Form 10-Q for additional information on discontinued operations.10-K.

4133
Table of Contents

Comparison of Three Months Ended March 31,September 30, 2021 to Three Months Ended March 31,September 30, 2020

Consolidated Results

The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the three months ended March 31,September 30, 2021 and 2020 (amounts in thousands, other than percentages, which may not add due to rounding):
 Three Months EndedChange in
 March 31, 2021March 31, 2020DollarsPercentage
Net sales$492,604 100.0%$553,297 100.0%$(60,693)(11.0)%
Cost of sales362,698 73.6%420,902 76.1%(58,204)(13.8)%
Gross profit129,906 26.4%132,395 23.9%(2,489)(1.9)%
Selling, general and administrative expenses74,223 15.1%85,447 15.4%(11,224)(13.1)%
Amortization of acquired intangible assets2,145 0.4%3,174 0.6%(1,029)(32.4)%
Productivity and transformation costs4,553 0.9%11,514 2.1%(6,961)(60.5)%
Proceeds from insurance claim(592)(0.1)%(400)(0.1)%(192)*
Long-lived asset and intangibles impairment— —%13,525 2.4%(13,525)(100.0)%
Operating income49,577 10.1%19,135 3.5%30,442 159.1%
Interest and other financing expense, net2,030 0.4%4,037 0.7%(2,007)(49.7)%
Other expense (income), net1,566 0.3%(260)—%1,826 *
Income from continuing operations before income taxes and equity in net loss of equity-method investees45,981 9.3%15,358 2.8%30,623 199.4%
Provision (benefit) for income taxes11,797 2.4%(10,242)(1.9)%22,039 *
Equity in net (income) loss of equity-method investees(70)—%564 0.1%(634)*
Net income from continuing operations$34,254 7.0%$25,036 4.5%$9,218 36.8%
Net loss from discontinued operations, net of tax— —%(697)(0.1)%697 *
Net income$34,254 7.0%$24,339 4.4%$9,915 40.7%
Adjusted EBITDA$73,752 15.0%$60,690 11.0%$13,062 21.5%
Diluted net income per common share from continuing operations$0.34 $0.24 $0.10 41.7%
Diluted net loss per common share from discontinued operations— (0.01)0.01 *
Diluted net income per common share$0.34 $0.23 $0.11 47.8%
 Three Months EndedChange in
 September 30, 2021September 30, 2020DollarsPercentage
Net sales$454,903 100.0%$498,627 100.0%$(43,724)(8.8)%
Cost of sales349,485 76.8%379,463 76.1%(29,978)(7.9)%
Gross profit105,418 23.2%119,164 23.9%(13,746)(11.5)%
Selling, general and administrative expenses73,989 16.3%79,521 15.9%(5,532)(7.0)%
Amortization of acquired intangible assets2,095 0.5%2,433 0.5%(338)(13.9)%
Productivity and transformation costs3,983 0.9%1,433 0.3%2,550 177.9%
Proceeds from insurance claim(196)—%— —%(196)*
Long-lived asset impairment— —%32,497 6.5%(32,497)(100.0)%
Operating income25,547 5.6%3,280 0.7%22,267 678.9%
Interest and other financing expense, net1,856 0.4%2,453 0.5%(597)(24.3)%
Other income, net(788)(0.2)%(1,373)(0.3)%585 (42.6)%
Income from continuing operations before income taxes and equity in net loss of equity-method investees24,479 5.4%2,200 0.4%22,279 1,012.7%
Provision for income taxes4,542 1.0%12,962 2.6%(8,420)(65.0)%
Equity in net loss of equity-method investees526 —%19 —%507 2,668.4%
Net income (loss) from continuing operations$19,411 4.3%$(10,781)(2.2)%$30,192 *
Net income from discontinued operations, net of tax— —%11,266 2.3%(11,266)(100.0)%
Net income$19,411 4.3%$485 0.1%$18,926 3,902.3%
Adjusted EBITDA$47,316 10.4%$54,895 11.0%$(7,579)(13.8)%
Diluted net income (loss) per common share from continuing operations$0.20 $(0.11)$0.31 *
Diluted net income per common share from discontinued operations— 0.11 (0.11)(100.0)%
Diluted net income per common share$0.20 $— $0.20 100.0%

* Percentage is not meaningful due to one or more numbers being negative.a comparison of a positive figure and a negative figure.

Net Sales

Net sales for the three months ended September 30, 2021 were $454.9 million, a decrease of $43.7 million, or 8.8%, as compared to $498.6 million in the three months ended March 31, 2021 were $492.6 million, a decrease of $60.7 million, or 11.0%, as compared to $553.3 million in the three months endedMarch 31, 2020.September 30, 2020. On a constant currency basis, and adjusted for the impact of divestitures and discontinued brands, net sales decreased approximately 6.0%$0.6 million and 0.1% from the prior year quarter. Net sales on a constant currency basis, adjusted for the impact of divestitures and discontinued brands, decreased in bothquarter driven by the North America and International reportable segments.segment. Further details of changes in adjusted net sales by segment are provided below in the Segment Resultssection.

4234
Table of Contents
Gross Profit

Gross profit for the three months ended March 31,September 30, 2021 was $129.9$105.4 million, a decrease of $2.5$13.7 million, or 1.9%11.5%, as comparedcompared to the prior year quarter primarily driven by lower sales.quarter. Gross profit margin was 26.4%23.2% of net sales, compared to 23.9% in the prior year quarter. The increase in margingross profit decrease was driven primarily by cost savings from the Company's productivity and transformation initiatives, favorable product mix and lower trade promotion costs in both our North America reportable segment, and mostly by the United States operating segment, as a result of lower net sales when compared with the prior year period as well as higher delivery and warehouse expenses. The decrease in the North America reportable segment was offset in part by an increase in the International reportable segment, due to the performance of the two UK operating segments. The Ella's Kitchen UK operating segment had higher net sales than the prior year quarter due to COVID-driven consumer demand issues in the prior year period which negatively impacted prior year net sales as well as lower cost of sales in the current year due to cost savings, partially offset by higher delivery and warehouse expense in the current year. The other UK operating segment, Hain United Kingdom, delivered improved gross margins versus prior year driven by the implementation of productivity initiatives and the divestiture of the low gross margin fruit business.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $74.2$74.0 million for the three months ended March 31,September 30, 2021, a decrease of $11.2$5.5 million, or 13.1%7.0%, from $85.4$79.5 million for the prior year quarter. The decrease occurred primarily in the United States and Europe operating segments. The decrease in the United States operating segment was primarily due to lower marketing and advertising costs, salaries, consulting expense, travel and entertainment expenses broker trade accruals and corporate expenses. Some of the decrease drivers were part of our productivity and transformation initiatives. Selling, general and administrative expenses as a percentage of net sales was 15.1% in the three months ended March 31, 2021 compared to 15.4%current year. The decrease in the prior year quarter, reflecting a decrease of 30 basis points primarily attributableEurope operating segment was due to the aforementioned items.lower broker commissions.

Amortization of Acquired Intangible Assets

Amortization of acquired intangibles was $2.1 million for the three months ended March 31,September 30, 2021, a decrease of $1.0$0.3 million from $3.2$2.4 million in the prior year quarter. The decrease was due to prior year dispositions that occurred in the elimination of the Fruit business intangible amortization during the third quarterlater part of fiscal 2021 and finite-lived intangibles from historical acquisitions becoming fully amortized or impaired during fiscal year 2020, partially offset by amortization from some of the indefinite-lived intangibles being changed to finite-lived intangibles during the first quarter of fiscal 2021..

Productivity and Transformation Costs

Productivity and transformation costs were $4.6$4.0 million for the three months ended March 31,September 30, 2021 a decrease, an increase of $7.0$2.6 million from $11.5$1.4 million in the prior year quarter. The decreaseincrease was primarily due to highera $1.6 million increase related to costs incurred for consulting fees related to supply chain optimization and severance costs incurred in connection with the Company’sother productivity and transformation initiatives in the prior year quarter and fewer comparable costs incurred in the current year quarter.initiatives.

Long-lived Asset and Intangibles Impairment

During the three months ended September 30, 2020, the Company recognized a pre-tax impairment charge of $32.5 million related to the reserve recorded against the assets of the Company's United Kingdom fruit business (see Note 4, Dispositions, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q). There werewas no long-lived asset and intangible impairment chargescharge recorded in the corresponding period in the three months ended March 31,September 30, 2021. In comparison, during the three months ended March 31, 2020, the Company recorded pre-tax impairment charges of $13.5 million of which $2.1 million related to certain tradenames within the Company's North America segment, $5.5 million related to certain tradenames within the Company's International segment and $5.9 million related to a write-down of certain machinery and equipment in the United States and Europe used to manufacture certain slow moving or low margin SKUs.

Operating Income

Operating income for the three months ended March 31,September 30, 2021 was $49.6$25.5 million compared to $19.1$3.3 million in the prior year quarter as a result of the items described above.

Interest and Other Financing Expense, Net

Interest and other financing expense, net totaled $2.0$1.9 million for the three months ended March 31,September 30, 2021, a decrease of $2.0$0.6 million, or 49.7%24.3%, from $4.0$2.5 million in the prior year quarter. The decrease resulted primarily from lower interest expense as a result of lower outstanding debt and lower variable interest rates on the portion of the debt not hedged by the derivatives.applied to borrowings outstanding under our revolving credit facility. See Note 9, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Other Expense (Income),Income, Net

Other expense, income, net totaled $1.6$0.8 million for the three months ended March 31,September 30, 2021, compared to income of $0.3$1.4 million in the prior year quarter.quarter. The change from income to expense was primarily attributable to a losslower gain on the sale of the Fruit business which occurredand higher realized foreign currency losses in the current year quarter.year.

4335
Table of Contents
Income from Continuing Operations Before Income Taxes and Equity in Net Loss of Equity-Method Investees

Income before income taxes and equity in net loss of our equity-method investees for the three months ended March 31,September 30, 2021 was $46.0was $24.5 million compared to $15.4$2.2 million in the prior year quarter. The increase was due to the items discussed above.

Provision (Benefit) for Income Taxes

The provision (benefit) for income taxes includes federal, foreign, state and local income taxes. Our income tax expense from continuing operations was $11.8$4.5 million for the three months ended March 31, September 30, 2021 compared to an income tax benefitexpense of $10.2$13.0 million in the prior year quarter.

The effective income tax rate from continuing operations was an expense of 25.7%18.6% and a benefit of 66.7%589.2% for the three months ended March 31, September 30, 2021 and March 31,2020, respectively. Lower effective income tax rate relative to our statutory tax rates for the current quarter is mainly due to the reversal of uncertain tax position accruals based on filing and approval of certain elections by the tax authorities. In addition, the effective income tax rates from continuing operations for the three months ended September 30, 2021 and 2020 respectively. Thewere negatively impacted by provisions in the Tax Cuts and Jobs Act (the "Tax Act"), primarily related to Global Intangible Low Taxed Income ("GILTI") and limitations on the deductibility of executive compensation. Furthermore, the effective income tax rate from continuing operations for the three months ended March 31, 2021 September 30, 2020 was negatively impacted by various discrete items including the finalizationtax impact of fiscal year 2020the United Kingdom fruit business reserve, the legal entity reorganization, and the UK rate change. The effective income tax returns. The income tax benefit forrates in each period were also impacted by the three months endedMarch 31, 2020 was primarily due to the benefits from the Coronavirus Aid, Relief,geographical mix of earnings and Economic Security Act (the "CARES Act") tax loss carryback.state valuation allowance.

Our effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.

Equity in Net (Income) Loss of Equity-Method Investees

Our equity in net (income) loss from our equity-method investments for the three months ended March 31,September 30, 2021 was income of$0.5 million and less than $0.1 million compared to a loss of $0.6 million in the prior year quarter. See Note 13, Investments, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Net Income (Loss) from Continuing Operations

Net income from continuing operations for the three months ended March 31,September 30, 2021 was $34.3$19.4 million, or $0.34$0.20 per diluted share, compared to net incomeloss of $25.0$10.8 million, or $0.24$0.11 per diluted share, for the three months ended March 31,September 30, 2020. The increase in netchange to income from continuing operationsloss was attributable to the factors noted above.

Net LossIncome from Discontinued Operations, Net of Tax

There was no net lossNet income from discontinued operations, net of tax, for the three months ended March 31, 2021, compared to a loss of $0.7September 30, 2020 was $11.3 million, inor $0.11 per diluted share.

During the three months ended March 31,September 30, 2020,. the Company recognized a $11.3 million adjustment to the Tilda business primarily related to the recognition of a deferred tax benefit.

See Note 4, Dispositions, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q for further discussion.

Net Income

Net income for the three months ended March 31,September 30, 2021 was $34.3$19.4 million, or $0.34$0.20 per diluted share, compared to net income of $24.3 $0.5 million, or $0.23$0.00 per diluted share, in the prior year quarter. The change to net income was attributable to the factors noted above.

Adjusted EBITDA

Our Adjusted EBITDA was $73.8$47.3 million and $60.7$54.9 million for the three months ended March 31,September 30, 2021 and 2020, respectively, as a result of the factors discussed above and the adjustments described in the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures presented following the discussion of our results of operations.
4436
Table of Contents

Segment Results

The following table provides a summary of net sales and operating income (loss) by reportable segment for the three months ended March 31,September 30, 2021 and 2020:
(dollars in thousands)North AmericaInternationalCorporate and OtherConsolidated
Net sales
Three months ended 3/31/21$287,500 $205,104 $— $492,604 
Three months ended 3/31/20320,440 232,857 — 553,297 
$ change$(32,940)$(27,753)n/a$(60,693)
% change(10.3)%(11.9)%n/a(11.0)%
Operating income (loss)
Three months ended 3/31/21$39,492 $26,774 $(16,689)$49,577 
Three months ended 3/31/2028,873 18,660 (28,398)19,135 
$ change$10,619 $8,114 $11,709 $30,442 
% change36.8 %43.5 %*159.1 %
Operating income (loss) margin
Three months ended 3/31/2113.7 %13.1 %n/a10.1 %
Three months ended 3/31/209.0 %8.0 %n/a3.5 %
(dollars in thousands)North AmericaInternationalCorporate and OtherConsolidated
Net sales
Three months ended 9/30/21$265,525 $189,378 $— $454,903 
Three months ended 9/30/20280,668 217,959 — 498,627 
$ change$(15,143)$(28,581)n/a$(43,724)
% change(5.4)%(13.1)%n/a(8.8)%
Operating income (loss)
Three months ended 9/30/21$16,842 $24,069 $(15,364)$25,547 
Three months ended 9/30/2033,256 (15,889)(14,087)3,280 
$ change$(16,414)$39,958 $(1,277)$22,267 
% change(49.4)%*(9.1)%678.9 %
Operating income (loss) margin
Three months ended 9/30/216.3 %12.7 %n/a5.6 %
Three months ended 9/30/2011.8 %(7.3)%n/a0.7 %

* Percentage is not meaningful due to one or more numbers being negative.a comparison of a positive figure and a negative figure.

North America

NetOur net sales in the North America reportable segment for the three months ended March 31,September 30, 2021 were $287.5$265.5 million, a decrease of $32.9$15.1 million, or 10.3%5.4%, from net sales of $320.4$280.7 million in the prior year quarter. On a constant currency basis, adjusted for the impact of divestitures and discontinued brands, net sales decreased by 7.9% from1.3%. In the prior year quarter. On an adjusted basis, the decrease was primarily driven by a large program with a wholesale club which was not repeatedUnited States operating segment sales decreased due to sales normalization in the current quarteryear, given last year's COVID impact which positively impacted prior year sales, offset in part by stronger sales in tea, baby food and pantry stockingcertain snack products in the prior year quarter as a result of stay-at-home orders atcurrent year. In the beginning ofCanada operating segment sales decreased primarily due to lower hand sanitizer sales in the COVID-19 pandemic.current year. Operating income in North America for the three months ended March 31,September 30, 2021 was $39.5$16.8 million, an increasea decrease of $10.6$16.4 million from $28.9$33.3 million in the prior year quarter due toquarter. The decrease was driven by lower trade promotion costs, a favorable product mix,sales in the current year when compared with the prior year period and higher cost of goods sold largely because of an increase in delivery and warehouse expenses, partially offset by lower selling, general and administrative expenses and supply chain cost efficiencies gained as a result of the Company's productivity and transformation initiatives.expenses.

International

NetOur net sales in the International reportable segment for the three months ended March 31,September 30, 2021 were $205.1$189.4 million, a decrease of $27.8$28.6 million, or 11.9%13.1%, from net sales of $232.9$218.0 million in the prior year quarter. On a constant currency basis, and adjusted for the impact of divestitures and discontinued brands, net sales decreased by 2.6%increased 1.6% from the prior year quarter. On an adjusted basis, the decrease was mainlyquarter due to United Kingdom customer inventory reductions that were elevated in three months ended December 31, 2020 in anticipationthe performance of potential Brexit supply disruptions as well as pantry stockingthe two UK operating segments. Ella's Kitchen UK benefited from improved demand given the COVID impact on baby food consumption in the prior year quarter as a result of stay-at-home orders at the beginning of the COVID-19 pandemic.year. Hain United Kingdom benefited from higher soup sales versus prior year. Operating income in our International reportable segment for the three months ended March 31,September 30, 2021 was $26.8$24.1 million, compared toan increase of $40.0 million from operating incomeloss of $18.7$15.9 million for the three months ended March 31, 2020, anSeptember 30, 2020. The increase of $8.1 million due toreflects lower trade promotion costs supply chain cost efficienciesin the current year from productivity initiatives and lower selling, general and administrative expenses.non-recurring impairment charges associated with the fruit business impairment that was recognized in the prior year.
4537
Table of Contents

Corporate and Other

Our Corporate and Other category consists of expenses related to the Company’s centralized administrative functions, which do not specifically relate to an operating segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to our entire enterprise as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a whole. Our operating loss in Corporate and Other expenses for the three months ended March 31,September 30, 2021 were $16.7was $15.4 million, a decreasean increase of $11.7$1.3 million, from $28.4 million. Included in the three months ended March 31, 2020 was a tradename impairment chargeoperating loss of $7.6 million compared with no tradename impairment charges in the three months ended March 31, 2021. In addition, the decrease is due to Productivity and transformation costs included in Corporate and Other, which for the three months ended March 31, 2021 were $2.8 million, a decrease of $2.8 million, from $5.6$14.1 million for the three months ended March 31, 2020.

Refer to Note 18, Segment Information, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

46
Table of Contents
Comparison of Nine Months Ended March 31, 2021 to Nine Months Ended March 31, 2020

Consolidated Results

The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the nine months ended March 31, 2021 and 2020 (amounts in thousands, other than percentages, which may not add due to rounding):
 Nine Months EndedChange in
 March 31, 2021March 31, 2020DollarsPercentage
Net sales$1,519,649 100.0%$1,542,157 100.0%$(22,508)(1.5)%
Cost of sales1,140,614 75.1%1,206,324 78.2%(65,710)(5.4)%
Gross profit379,035 24.9%335,833 21.8%43,202 12.9%
Selling, general and administrative expenses236,995 15.6%245,205 15.9%(8,210)(3.3)%
Amortization of acquired intangible assets6,771 0.4%9,446 0.6%(2,675)(28.3)%
Productivity and transformation costs12,371 0.8%37,949 2.5%(25,578)(67.4)%
Proceeds from insurance claim(592)—%(2,962)(0.2)%2,370 *
Long-lived asset and intangibles impairment57,676 3.8%15,414 1.0%42,262 274.2%
Operating income65,814 4.3%30,781 2.0%35,033 113.8%
Interest and other financing expense, net6,820 0.4%15,068 1.0%(8,248)(54.7)%
Other (income) expense, net(852)(0.1)%2,312 0.1%(3,164)*
Income from continuing operations before income taxes and equity in net loss of equity-method investees59,846 3.9%13,401 0.9%46,445 346.6%
Provision (benefit) for income taxes33,197 2.2%(9,753)(0.6)%42,950 *
Equity in net loss of equity-method investees1,025 0.1%1,219 0.1%(194)(15.9)%
Net income from continuing operations$25,624 1.7%$21,935 1.4%$3,689 16.8%
Net income (loss) from discontinued operations, net of tax11,255 0.7%(105,581)(6.8)%116,836 *
Net income (loss)$36,879 2.4%$(83,646)(5.4)%$120,525 *
Adjusted EBITDA$190,838 12.6%$137,827 8.9%$53,011 38.5%
Diluted net income per common share from continuing operations$0.25 $0.21 $0.04 19.0%
Diluted net income (loss) per common share from discontinued operations0.11 (1.01)1.12 *
Diluted net income (loss) per common share$0.36 $(0.80)$1.16 *

* Percentage is not meaningful due to one or more numbers being negative.












47
Table of Contents
Net Sales

Net sales for the nine months endedMarch 31, 2021 were $1,519.6 million, a decrease of $22.5 million, or 1.5%, as compared to $1,542.2 million in the nine months endedMarch 31, 2020 as a result of a decrease in sales in the North America reportable segments. On a constant currency basis, adjusted for the impact of divestitures and discontinued brands, net sales increased approximately 1.6% from the prior comparable period. On an adjusted basis, net sales increased in both North America and International segments. Further details of changes in adjusted net sales by segment are provided below in the Segment Results section.

Gross Profit

Gross profit for the nine months ended March 31, 2021 was $379.0 million, an increase of $43.2 million, or 12.9%, as compared to the prior year comparable period. Gross profit margin was 24.9% of net sales, compared to 21.8% in the prior year comparable period. The increase was driven by cost savings from the Company's productivity and transformation initiatives, favorable product mix and lower trade promotion costs in both our North America and International reportable segments.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $237.0 million for the nine months ended March 31, 2021, a decrease of $8.2 million, or 3.3%, from $245.2 million for the prior year comparable period. The decrease was due to lower broker trade accruals, salaries, consulting expense, travel and entertainment expenses and corporate expenses. Selling, general and administrative expenses as a percentage of net sales was 15.6% in the nine months ended March 31, 2021 compared to 15.9% in the prior year comparable period, attributable to the aforementioned items.

Amortization of Acquired Intangible Assets

Amortization of acquired intangibles was $6.8 million for the nine months ended March 31, 2021, a decrease of $2.7 million from $9.4 million in the prior year comparable period. The decrease was due to the elimination of the Fruit business intangible amortization since the first quarter of fiscal 2021 and finite-lived intangibles from historical acquisitions becoming fully amortized or impaired during fiscal year 2020, partially offset by amortization from some of the indefinite-lived intangibles being changed to finite-lived intangibles during the first quarter of fiscal 2021.

Productivity and Transformation Costs

Productivity and transformation costs were $12.4 million for the nine months ended March 31, 2021, a decrease of $25.6 million from $37.9 million in the prior year comparable period. The decrease was primarily due to higher consulting fees and severance costs incurred in connection with the Company’s productivity and transformation initiatives in the prior year period and fewer comparable costs incurred in fiscal 2021.

Proceeds from Insurance Claim

In the third quarter of fiscal year 2021, the Company received $0.6 million as payment from an insurance claim related to a litigation described in Note 17, Commitments and Contingencies. In July of 2019, the Company received $7.0 million as partial payment from an insurance claim relating to business disruption costs associated with a co-packer. Of this amount, $4.5 million was recognized in fiscal 2019 as it related to reimbursement of costs already incurred, with the remaining $2.9 million recognized in the nine months ended March 31, 2020.

Long-lived Asset and Intangibles Impairment

During the nine months ended March 31, 2021, the Company recognized a pre-tax impairment charge of $57.7 million, of which $56.1 million related to the reserve recorded against the assets of the Company's Fruit business (see Note 4, Dispositions, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q) and $1.6 million related to impairment of property, plant and equipment and other non-current assets not related to the Fruit business. During the nine months ended March 31, 2020, the Company recorded a pre-tax impairment charge of $15.4 million, of which $4.0 million related to certain tradenames within the Company's North America segment, $5.5 million related to certain tradenames within the Company's International segment and $5.9 million related to a write-down of certain machinery and equipment in the United States and Europe used to manufacture certain slow moving or low margin SKUs.

48
Table of Contents
Operating Income

Operating income for the nine months ended March 31, 2021 was $65.8 million compared to $30.8 million in the prior year comparable period because of the items described above.

Interest and Other Financing Expense, Net

Interest and other financing expense, net totaled $6.8 million for the nine months ended March 31, 2021, a decrease of $8.2 million, or 54.7%, from $15.1 million in the prior year comparable period. The decrease resulted primarily from lower interest expense as a result of lower outstanding debt and lower variable interest rates on the portion of the debt not hedged by the derivatives. See Note 9, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Other (Income) Expense, Net

Other income, net totaled $0.9 million for the nine months ended March 31, 2021, compared to expense of $2.3 million in the prior year comparable period. The change from expense to income was primarily attributable to net unrealized foreign currency losses in fiscal 2020 being higher than in fiscal 2021 principally due to foreign currency movements on the remeasurement of foreign currency denominated loans, partially offset by loss on sale of businesses of $1.3 million in fiscal 2021 compared with gain on sale of business of $2.1 million in fiscal 2020.

Income from Continuing Operations Before Income Taxes and Equity in Net Loss of Equity-Method Investees

Income from continuing operations before income taxes and equity in net loss of our equity-method investees for the nine months ended March 31, 2021 was $59.8 million compared to $13.4 million in the prior year comparable period. The increase was due to the items discussed above.

Provision (Benefit) for Income Taxes

The provision for income taxes includes federal, foreign, state and local income taxes. Our income tax expense from continuing operations was $33.2 million for the nine months ended March 31, 2021 compared to a tax benefit of $9.8 million in the prior year comparable period.

The effective income tax rate from continuing operations was an expense of 55.5% and benefit of 72.8% for the nine months ended March 31, 2021 and 2020, respectively. The effective income tax rate from continuing operations for the period ended March 31, 2021 was impacted by various discrete items including the tax impact of the sale of the Fruit business, the enacted change in the United Kingdom's corporate income tax rate to 19% and a legal entity reorganization completed during the quarter ended September 30, 2020. The income tax benefit for the nine months endedMarch 31, 2020 was mainly due to the benefits from the CARES Act carryback.

Through the nine months ended March 31, 2021, the Company received $53.8 million including $1.3 million of interest from the CARES Act tax loss carryback refund claims.

Our effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.

Equity in Net Loss of Equity-Method Investees

Our equity in net loss from our equity-method investments for the nine months ended March 31, 2021 was $1.0 million compared to $1.2 million in the prior year comparable period. See Note 13, Investments, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Net Income from Continuing Operations

Net income from continuing operations for the nine months ended March 31, 2021 was $25.6 million, or $0.25 per diluted share, compared to $21.9 million, or $0.21 per diluted share, for the nine months ended March 31, 2020. The increase in net income from continuing operations was attributable to the factors noted above.

Net Income (Loss) from Discontinued Operations, Net of Tax
49
Table of Contents

Net income (loss) from discontinued operations, net of tax, for the nine months ended March 31, 2021 was income of $11.3 million, or $0.11 per diluted share, compared to a loss of $105.6 million, or $1.01 per diluted share, in the nine months ended March 31, 2020.

During the nine months ended March 31, 2021, the Company recognized a $11.3 million adjustment to the Tilda business primarily related to the recognition of a deferred tax benefit. Net loss from discontinued operations, net of tax, for the nine months ended March 31, 2020 included a reclassification of $95.1 million of cumulative translation losses from accumulated other comprehensive loss to the Company's results of the Tilda business' discontinued operations. The income tax expense from discontinued operations of $13.5 million for the nine months ended March 31, 2020 was impacted by $15.3 million of tax related to the tax gain on the sale of the Tilda entities.

See Note 4, Dispositions, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q for further discussion.

Net Income (Loss)

Net income for the nine months ended March 31, 2021 was $36.9 million, or $0.36 per diluted share, compared to a net loss of $83.6 million, or $0.80 per diluted share, in the prior year comparable period. The change from net loss to net income was attributable to the factors noted above.

Adjusted EBITDA

Our Adjusted EBITDA was $190.8 million and $137.8 million for the nine months ended March 31, 2021 and 2020, respectively, as a result of the factors discussed above and the adjustments described in the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures presented following the discussion of our results of operations.
50
Table of Contents

Segment Results

The following table provides a summary of net sales and operating income by reportable segment for the nine months ended March 31, 2021 and 2020:
(dollars in thousands)North AmericaInternationalCorporate and OtherConsolidated
Net sales
Nine months ended 3/31/21$850,780 $668,869 $— $1,519,649 
Nine months ended 3/31/20872,834 669,323 — 1,542,157 
$ change$(22,054)$(454)n/a$(22,508)
% change(2.5)%(0.1)%n/a(1.5)%
Operating income (loss)
Nine months ended 3/31/21$105,188 $8,144 $(47,518)$65,814 
Nine months ended 3/31/2064,067 40,666 (73,952)30,781 
$ change$41,121 $(32,522)$26,434 $35,033 
% change64.2 %(80.0)%*113.8 %
Operating income (loss) margin
Nine months ended 3/31/2112.4 %1.2 %n/a4.3 %
Nine months ended 3/31/207.3 %6.1 %n/a2.0 %

* Percentage is not meaningful due to one or more numbers being negative.

North America

Our net sales in the North America reportable segment for the nine months ended March 31, 2021 were $850.8 million, a decrease of $22.1 million, or 2.5%, from net sales of $872.8 million in the prior year comparable period. On a constant currency basis, adjusted for the impact of divestitures and discontinued brands, net sales increased by 2.0%. On an adjusted basis, North America segment sales increased by 2.0% due to higher sales in first two quarters of the current year compared to the prior year driven by an increase in overall demand for our products as a result of increased at-home food consumption, most notably in our snacks, tea, yogurt, and certain personal care product categories. This increase was partially offset by a decrease in the third quarter due to reasons discussed above in the Comparison of Three Months Ended March 31, 2021 to Three Months Ended March 31, 2020 section. Operating income in North America for the nine months ended March 31, 2021 was $105.2 million, an increase of $41.1 million from $64.1 million in the prior year comparable period. The increase was driven by lower trade promotion costs, a favorable product mix, lower selling, general and administrative expenses and supply chain cost efficiencies gained with the Company's productivity and transformation initiatives.

International

Our net sales in the International reportable segment for the nine months ended March 31, 2021 were $668.9 million, a decrease of $0.5 million, or 0.1%, from net sales of $669.3 million in the prior year comparable period. On a constant currency basis, and adjusted for the impact of divestitures and discontinued brands, net sales increased 1.2% from the prior year comparable period primarily due to an increase in overall demand for our products including the growth in our plant-based food and beverage products. This increase was partially offset by a decrease in the third quarter due to reasons discussed above in the Comparison of Three Months Ended March 31, 2021 to Three Months Ended March 31, 2020 section. Operating income in our International reportable segment for the nine months ended March 31, 2021 was $8.1 million, a decrease of $32.5 million from operating income of $40.7 million for the nine months ended March 31, 2020. The decrease was primarily due to a reserve of $56.1 million recorded against the Fruit business. Without this charge, operating income would have increased by $23.6 million driven by improvement in gross profit from adjusted net sales growth and the implementation of productivity initiatives.
51
Table of Contents

Corporate and Other

Our Corporate and Other category consists of expenses related to the Company’s centralized administrative functions, which do not specifically relate to an operating segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to our entire enterprise as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a whole. Our Corporate and Other expenses for the nine months ended March 31, 2021 were $47.5 million, a decrease of $26.4 million, from $74.0 million in the prior year period. This change was primarily related to a decrease in productivity and transformation costs included in Corporate and Other which for the nine months ended March 31, 2021 were $6.3 million, a decrease of $19.8 million, from $26.1$2.1 million for the nine months ended March 31, 2020. Included in the nine months ended March 31, 2020 was a tradename impairment charge of $7.6 million compared with no tradename impairment charges in the three months ended March 31, 2021. The decreaseSeptember 30, 2021, an increase of $26.4$1.3 million was relatedfrom $0.8 million for the three months ended September 30, 2020 primarily due to Corporate and Other expenses was partially offset by lower marketing and advertising expenses.higher consulting costs.

Refer to Note 18, Segment Information, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Liquidity and Capital Resources

We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available to us under our Amended Credit Agreement. As of March 31, 2021, $738.6 million was available under the Amended Credit Agreement, and the Company was in compliance with all associated covenants. We believe that our cash flows from operations and borrowing capacity under our Amended Credit Agreement will be adequate to meet anticipated operating and other expenditures for the foreseeable future.

Our cash and cash equivalents balance increased $15.2 decreased $46.9 million at March 31,September 30, 2021 to $53.0$29.0 million as comparedcompared to $37.8$75.9 million at June 30, 2020.2021. Our working capital from continuing operations was $264.9$232.3 million at March 31,September 30, 2021, an increasea decrease of $4.2$52.4 million from $260.7$284.7 million at the end of fiscal 2020.2021 as we continued to reduce product inventories. Additionally, our long-term debt increased $114.9 million at September 30, 2021 to $345.4 million as compared to $230.5 million at June 30, 2021 as a result of $120.0 million of additional borrowings to support the share repurchases carried out in the quarter offset by $5.0 million of repayments. As of September 30, 2021, $648.6 million was available under the Amended Credit Agreement as compared with $763.6 million as of June 30, 2021, and the Company was in compliance with all associated covenants.

Liquidity is affected by many factors, some of which are based on normal ongoing operations of the Company’s business and some of which arise from fluctuations related to global economics and markets. Our cash balances are held in the United States, United Kingdom, Canada, Europe, Middle East and India. As of March 31,September 30, 2021, substantially all of the total cash balance from continuing operations was held outside of the United States dueStates. It is our current intent to debt repayments made towardsindefinitely reinvest our revolving credit facility at the end of the period byremaining foreign earnings outside the United States operating segment.States.

We maintain our cash and cash equivalents primarily in money market funds or their equivalent. As of March 31,September 30, 2021, all of our investments were expected to mature in less than three months. Accordingly, we do not believe that our investments have significant exposure to interest rate risk.risk. Cash provided by (used in) operating,operating, investing and financing activities is summarized below.
Three Months Ended September 30,Change in
(amounts in thousands)20212020Dollars
Cash flows provided by (used in):
Operating activities from continuing operations$37,586 $40,669 $(3,083)
Investing activities from continuing operations(18,054)(7,728)(10,326)
Financing activities from continuing operations(63,515)(35,959)(27,556)
Effect of exchange rate changes on cash from continuing operations(2,926)2,500 (5,426)
Net decrease in cash and cash equivalents$(46,909)$(518)$(46,391)

Nine Months Ended March 31,Change in
(amounts in thousands)20212020Dollars
Cash flows provided by (used in):
Operating activities from continuing operations$146,517 $64,092 $82,425 
Investing activities from continuing operations(25,968)(32,533)6,565 
Financing activities from continuing operations(110,956)(18,917)(92,039)
Effect of exchange rate changes on cash from continuing operations5,650 (2,110)7,760 
Increase in cash from continuing operations15,243 10,532 4,711 
Decrease in cash from discontinued operations— (8,509)8,509 
Net increase in cash and cash equivalents$15,243 $2,023 $13,220 

Ca
Cashsh provided by operating activities from continuing operations was $146.5$37.6 million for the ninethree months ended March 31,September 30, 2021, an increasea decrease of $82.4$3.1 million from cash provided by operating activities from continuing operations of $64.1$40.7 million in the prior year period. This increasedecrease versus the prior period resulted primarily from an improvementfrom a reduction of $56.2$5.7 million in lower net income adjusted for non-cash charges netted by higher cash generation of $2.6 million from our working capital accounts.

5238
Table of Contents
charges in the current period. The larger non-cash adjustments to net income from continuing operations related to the LCasong-lived asset and intangibles impairment charge of $57.7 million during the nine months endedMarch 31, 2021 compared with $15.4 million in the prior year period as well as a change to deferred tax expense of $3.2 million in the current year period compared with deferred tax benefit of $9.0 million in the prior year period. The reason for the change to Long-lived asset and intangible impairment charge is discussed in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section entitled Comparison of Nine Months Ended March 31, 2021 to Nine Months Ended March 31, 2020. Compared to current year deferred tax expense, the prior year deferred tax benefit is primarily due to the CARES Act.Additionally, the increase in cash provided by operating activities from continuing operations resulted from greater cash generation of $26.3 million from our working capital accounts.

Cashh used in investing activities from continuing operations was $26.0$18.1 million for the ninethree months ended March 31,September 30, 2021, a decreasean increase of $6.6$10.3 million from $32.5$7.7 million in the prior year period primarily due to higher proceeds received in the current year period from the sale of businesses.increased capital expenditures.

CashCash used in financingfinancing activities from continuing operations was $111.0$63.5 million for the ninethree months ended March 31,September 30, 2021, an increase in cash used of $92.0$27.6 million compared to $18.9$36.0 million of cash used in the prior year period. Cash used in financing activities from continuing operations forperiod and the nine months ended March 31, 2021 included $25.0 million of net repayments of our revolving credit facility and $80.3 million ofincrease is primarily due to share repurchases. Cash used in financing activities from continuing operations for the nine months ended March 31, 2020 included $265.3 million of net repayments of our term loan, revolving credit facility and other debt and by $57.4 million for share repurchases, partially offset by $305.2 million related to the proceeds from the sale of Tilda.

Operating Free Cash Flow from Continuing Operations

Our Operating Free Cash Flowoperating free cash flow from continuing operations was $93.5$19.8 million forfor the ninethree months ended March 31,September 30, 2021, an improvementa decrease of $76.3$8.7 million compared to $17.1from $28.5 million in the ninethree months ended March 31,September 30, 2020. This improvementdecrease versus prior year resulted primarily from an improvementa decrease in cash flow from operations of $56.2$3.1 million in net income adjusted for non-cash charges indriven by the current periodreasons explained above and greater cash generationhigher capital expenditures of $26.3 million from our working capital accounts.$5.7 million. See the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation from our net cash provided by operating activities from continuing operations to Operating Free Cash Flowoperating free cash flow from continuing operations.

Share Repurchase Program

OnIn June 21, 2017 and August 2021, the Company’sCompany's Board of Directors authorized the repurchase of up to $250 million and $300 million of the Company’s issued and outstanding common stock.stock, respectively. Share repurchases under the 2021 authorization commenced in August 2021, after the 2017 authorization was fully utilized. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the ninethree months ended March 31,September 30, 2021, the Company repurchased 2,4084.525 million shares under the repurchase program for a total of $80.3$175.6 million, excluding commissions, at an average price of $33.33$38.80 per share. As of March 31,September 30, 2021, the Company had $109.5$206.8 million of remaining authorization under the share repurchase program. During the three months ended September 30, 2020, the Company repurchased 1.281 million shares under the repurchase program for a total of $42.0 million, excluding commissions, at an average price of $32.81 per share.

Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures
We have included in this report measures of financial performance that are not defined by accounting principles generally accepted in the United States (“U.S. GAAP”).GAAP. We believe that these measures provide useful information to investors and include these measures in other communications to investors.
For each of these non-U.S. GAAP financial measures, we are providing below a reconciliation of the differences between the non-U.S. GAAP measure and the most directly comparable U.S. GAAP measure, an explanation of why our management and Board of Directors believe the non-U.S. GAAP measure provides useful information to investors and any additional purposes for which our management and Board of Directors use the non-U.S. GAAP measures. These non-U.S. GAAP measures should be viewed in addition to, and not in lieu of, the comparable U.S. GAAP measures.
53
Table of Contents
Constant Currency Presentation
We believe that this measure provides useful information to investors because it provides transparency to underlying performance in our consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on year-to-year comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. As a result, the foreign currency impact is equal to the current year results in local currencies multiplied by the change in average foreign currency exchange rate between the current fiscal period and the corresponding period of the prior fiscal year.

Divestitures and Discontinued Brands

We also exclude the impact of divestitures and discontinued brands when comparing net sales to prior periods, which results in the presentation of certain non-U.S. GAAP financial measures. The Company's management believes that excluding the impact of divestitures and discontinued brands when presenting period-over-period results of net sales aids in comparability.

A reconciliation between reported and constant currency net sales adjusted for divestitures and discontinued brands increase (decrease) is as follows:
5439
Table of Contents
(amounts in thousands)(amounts in thousands)North AmericaInternationalHain Consolidated(amounts in thousands)North AmericaInternationalHain Consolidated
Net sales - Three Months Ended March 31, 2021$287,500 $205,104 $492,604 
Net sales - Three months ended September 30, 2021Net sales - Three months ended September 30, 2021$265,525 $189,378 $454,903 
Divestitures and discontinued brandsDivestitures and discontinued brands(320)(4,144)(4,464)Divestitures and discontinued brands(178)— (178)
Impact of foreign currency exchangeImpact of foreign currency exchange(2,042)(15,428)(17,470)Impact of foreign currency exchange(1,719)(8,269)(9,988)
Net sales on a constant currency basis adjusted for divestitures and discontinued brands - Three Months Ended March 31, 2021$285,138 $185,532 $470,670 
Net sales on a constant currency basis adjusted for divestitures and discontinued brands - Three months ended September 30, 2021Net sales on a constant currency basis adjusted for divestitures and discontinued brands - Three months ended September 30, 2021$263,628 $181,109 $444,737 
Net sales - Three Months Ended March 31, 2020$320,440 $232,857 $553,297 
Net sales - Three months ended September 30, 2020Net sales - Three months ended September 30, 2020$280,668 $217,959 $498,627 
Divestitures and discontinued brandsDivestitures and discontinued brands(10,717)(42,462)(53,179)Divestitures and discontinued brands(13,621)(39,630)(53,251)
Net sales adjusted for divestitures and discontinued brands - Three Months Ended March 31, 2020$309,723 $190,395 $500,118 
Net sales adjusted for divestitures and discontinued brandsNet sales adjusted for divestitures and discontinued brands$267,047 $178,329 $445,376 
Net sales declineNet sales decline(10.3)%(11.9)%(11.0)%Net sales decline(5.4)%(13.1)%(8.8)%
Impact of divestitures and discontinued brandsImpact of divestitures and discontinued brands3.0 %15.9 %8.2 %Impact of divestitures and discontinued brands4.7 %18.5 %10.7 %
Impact of foreign currency exchangeImpact of foreign currency exchange(0.6)%(6.6)%(3.2)%Impact of foreign currency exchange(0.6)%(3.8)%(2.0)%
Net sales decline on a constant currency basis adjusted for divestitures and discontinued brands(7.9)%(2.6)%(6.0)%
Net sales - Nine Months Ended March 31, 2021$850,780 $668,869 $1,519,649 
Divestitures and discontinued brands(4,105)(5,052)(9,157)
Impact of foreign currency exchange(2,144)(35,133)(37,277)
Net sales on a constant currency basis adjusted for divestitures and discontinued brands - Nine Months Ended March 31, 2021$844,531 $628,684 $1,473,215 
Net sales - Nine Months Ended March 31, 2020$872,834 $669,323 $1,542,157 
Divestitures and discontinued brands(44,120)(48,122)(92,242)
Net sales adjusted for divestitures and discontinued brands - Nine Months Ended March 31, 2020$828,714 $621,201 $1,449,915 
Net sales decline(2.5)%(0.1)%(1.5)%
Impact of divestitures and discontinued brands4.7 %6.5 %5.5 %
Impact of foreign currency exchange(0.2)%(5.2)%(2.4)%
Net sales growth on a constant currency basis adjusted for divestitures and discontinued brands2.0 %1.2 %1.6 %
Net sales (decline) growth on a constant currency basis adjusted for divestitures and discontinued brandsNet sales (decline) growth on a constant currency basis adjusted for divestitures and discontinued brands(1.3)%1.6 %(0.1)%

Adjusted EBITDA

Adjusted EBITDA is defined as net income (loss) before income taxes, net interest expense, depreciation and amortization, impairment of long-lived assets and intangibles,charges, equity in net (income) loss of equity-method investees, stock-based compensation, net, productivityrestructuring activities, litigation and transformation costs, SKU rationalizationrelated expenses, acquisitions and certain inventory write-downs,divestitures, unrealized currency gains and losses and other adjustments. The Company’s management believes that this presentation provides useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses this measure for reviewing the financial results of the Company and as a component of performance-based executive compensation. Adjusted EBITDA is a non-U.S. GAAP measure and may not be comparable to similarly titled measures reported by other companies.
We do not consider Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP. The principal limitation of Adjusted EBITDA is that it excludes certain expenses and income that are required by U.S. GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection with U.S. GAAP results.
5540
Table of Contents
A reconciliation of net income (loss) to Adjusted EBITDA is as follows:
Three Months Ended March 31,Nine Months Ended March 31,
(amounts in thousands)2021202020212020
Net income (loss)$34,254 $24,339 $36,879 $(83,646)
Net (loss) income from discontinued operations, net of tax— (697)11,255 (105,581)
Net income from continuing operations34,254 25,036 25,624 21,935 
Provision (benefit) for income taxes11,797 (10,242)33,197 (9,753)
Interest expense, net1,327 3,332 4,781 11,884 
Depreciation and amortization12,814 12,927 37,768 40,069 
Equity in net (income) loss of equity-method investees(70)564 1,025 1,219 
Stock-based compensation, net3,698 3,761 11,888 9,581 
Unrealized currency losses (gains)442 (1,011)(535)188 
Productivity and transformation costs3,915 10,967 10,428 37,402 
Proceeds from insurance claim(592)(400)(592)(2,962)
Long-lived asset and intangibles impairment— 13,525 57,676 15,414 
Warehouse/manufacturing consolidation and other costs3,598 537 7,313 3,055 
Loss on sale of businesses1,904 332 1,293 2,115 
Litigation and related expenses644 — 644 48 
Plant closure related costs21 — 17 2,354 
SKU rationalization and inventory write-down— 1,362 311 5,278 
Adjusted EBITDA$73,752 $60,690 $190,838 $137,827 
Three Months Ended September 30,
(amounts in thousands)20212020
Net income$19,411 $485 
Net income from discontinued operations— 11,266 
Net income (loss) from continuing operations19,411 (10,781)
Depreciation and amortization10,855 13,761 
Equity in net loss of equity-method investees526 19 
Interest expense, net1,146 2,154 
Provision for income taxes4,542 12,962 
Stock-based compensation4,287 4,367 
Unrealized currency gains(1,023)(1,202)
Litigation & related costs
Litigation expenses1,956 — 
Proceeds from insurance claim(196)— 
Restructuring activities
Plant closure related costs996 (6)
Productivity and transformation costs3,204 781 
Warehouse/manufacturing consolidation and other costs2,289 390 
Acquisitions & divestitures
Acquisitions & divestitures transaction costs, net(231)369 
Gain on sale of assets(446)— 
Gain on sale of businesses— (620)
Impairment charges
SKU rationalization and inventory write-down— 204 
Long-lived asset impairment— 32,497 
Adjusted EBITDA$47,316 $54,895 

Operating Free Cash Flow from Continuing Operations

In our internal evaluations, we use the non-U.S. GAAP financial measure “Operating Free Cash Flow from Continuing Operations.continuing operations.” The difference between Operating Free Cash Flowoperating free cash flow from continuing operations and cash flow provided by or used in operating activities from continuing operations, which is the most comparable U.S. GAAP financial measure, is that Operating Free Cash Flow from continuing operations reflects the impact of purchases of property, plant and equipment (capital spending). Since capital spending is essential to maintaining our operational capabilities, we believe that it is a recurring and necessary use of cash. As such, we believe investors should also consider capital spending when evaluating our cash provided by or used in operating activities. We view Operating Free Cash Flow from continuing operations as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments. We do not consider Operating Free Cash Flow from continuing operations in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP.
5641
Table of Contents

A reconciliation from cashCash flow provided by operating activities from continuing operations to Operating Free Cash Flowflow from continuing operations is as follows:
Nine Months Ended March 31,
(amounts in thousands)20212020
Cash flow provided by operating activities from continuing operations$146,517 $64,092 
Purchases of property, plant and equipment(53,062)(46,961)
Operating free cash flow from continuing operations$93,455 $17,131 
Three Months Ended September 30,
(amounts in thousands)20212020
Cash flow provided by operating activities from continuing operations$37,586 $40,669 
Purchases of property, plant and equipment(17,810)(12,155)
Operating Free Cash Flow from continuing operations$19,776 $28,514 


Off Balance Sheet Arrangements

At March 31,September 30, 2021, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K that have had, or are likely to have, a material current or future effect on our consolidated financial statements.

Critical Accounting Estimates

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States. The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. We believe in the quality and reasonableness of our critical accounting policies; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have applied. The accounting policies that have been identified as critical to our business operations and to understanding the results of our operations pertain to revenue recognition, trade promotions and sales incentives, valuation of accounts and chargeback receivable, valuation of long-lived assets, goodwill and intangible assets, stock-based compensation and valuation allowances for deferred tax assets. The application of each of these critical accounting policies and estimates is discussed in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020.2021.

Recent Accounting Pronouncements

Refer to Note 2, Basis of Presentation, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Seasonality

Certain of our product lines have seasonal fluctuations. Hot tea, hot-eating desserts and soup sales are stronger in colder months, while sales of snack foods, sunscreen and certain of our prepared food and personal care products are stronger in the warmer months. As such, our results of operations and our cash flows for any particular quarter are not indicative of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations. In recent years, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters.

Item 3.         Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes in market risk from those addressed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 20202021 during the ninethree months ended March 31,September 30, 2021. See the information set forth in Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk, of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020.2021.
5742
Table of Contents
Item 4.        Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), with the assistance of other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Our disclosure controls and procedures are intended to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Based on this review, our CEO and CFO have concluded that the disclosure controls and procedures were effective as of March 31,September 30, 2021.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect every misstatement. An evaluation of effectiveness is subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may decrease over time.

Changes in Internal Control Over Financial Reporting
There were no changes in our internal controls over financial reporting that occurred during the three months ended March 31,September 30, 2021 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
5843
Table of Contents
PART II - OTHER INFORMATION
Item 1.        Legal Proceedings

The information called for by this item is incorporated herein by reference to Note 17, Commitments and Contingencies, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Item 1A.    Risk Factors

There have been no material changes from the discussion of the material factors that make an investment in the Company speculative or risky contained in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2020,2021, filed with the SEC on August 25, 2020.26, 2021.

Item 2.        Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The table below sets forth information regarding repurchases by the Company of its common stock during the periods indicated.
Period(a)
Total Number
of Shares
Purchased (1)		(b)
Average
Price Paid
Per Share		(c)
Total Number of
Shares Purchased
as Part of
Publicly
Announced Plans		(d)
Maximum
Number of Shares
That May Yet be
Purchased Under
the Plans (in millions of dollars) (2)
January 1, 2021 - January 31, 202140,975 $39.90 — $118.1 
February 1, 2021 - February 28, 202113,764 42.24 5,283 $117.9 
March 1, 2021 - March 31, 2021199,173 41.85 199,173 $109.5 
Total253,912 $41.56 204,456 
Period(a)
Total number
of shares
purchased (1)
(b)
Average
price paid
per share
(c)
Total number of
shares purchased
as part of
publicly
announced plans
(d)
Maximum
number of shares
that may yet be
purchased under
the plans (in millions of dollars) (2)
July 1, 2021 - July 31, 20211,366,202 $39.69 1,366,202 $28.2 
August 1, 2021 - August 31, 2021915,378 38.22 891,346 $294.2 
September 1, 2021 - September 30, 20212,272,554 38.53 2,267,949 $206.8 
Total4,554,134 $38.81 4,525,497 

(1) Includes shares surrendered for payment of employee payroll taxes due on shares issued under stock-based compensation plans and shares repurchased under share repurchase programs approved by the Board of Directors. See (2) below for further details.
(2) OnIn June 21, 2017 and August 2021, the Company’s Board of Directors authorized the repurchase of up to $250 million and $300 million of the Company’s issued and outstanding common stock.stock, respectively. Share repurchases under the 2021 authorization commenced in August 2021, after the 2017 authorization was fully utilized. Repurchases may be made from time to time in the open market, pursuant to preset trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. During the three months ended March 31,September 30, 2021, the Company repurchased 2044,525 shares pursuant to the repurchase program for a total of $8.6$175.6 million, excluding commissions, at an average price of $41.86$38.80 per share. As of March 31,September 30, 2021, the Company had $109.5$206.8 million of remaining authorization under the share repurchase program.

5944
Table of Contents
Item 6.        Exhibits

Exhibit
Number
Description
3.1
3.23
Certificate of Amendment to Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2(b) of the Company’s Current Report on Form 8-K filed with the SEC on November 26, 2014).
3.3.2
Amended and Restated By-Laws (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 7, 2018).
4.1
Specimen of common stock certificate (incorporated by reference to Exhibit 4.1 of Amendment No. 1 to the Company’s Registration Statement on Form S-4 filed with the SEC on April 24, 2000).
10.1
Fifth Amendment to Third Amended and Restated Credit Agreement, dated September 17, 2021, by and among the Company, the Lenders party thereto and Bank of America, N.A., as administrative agent.
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
31.2
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
32.1
Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2
Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.
6045
Table of Contents
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 THE HAIN CELESTIAL GROUP, INC.
(Registrant)
Date:May 6,November 9, 2021/s/    Mark L. Schiller
 Mark L. Schiller,
President and
Chief Executive Officer
Date:May 6,November 9, 2021/s/   Javier H. Idrovo
 
Javier H. Idrovo,
Executive Vice President and
Chief Financial Officer
(Principal Financial and Accounting Officer)



6146